{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:53:17Z","timestamp":1793836397018,"version":"4.6.1"},"reference-count":279,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T00:00:00Z","timestamp":1754352000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetol Metab Syndr"],"DOI":"10.1186\/s13098-025-01884-5","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T10:59:33Z","timestamp":1754391573000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Curcumin as a promising therapeutic agent for diabetic neuropathy: from molecular mechanisms to functional recovery"],"prefix":"10.1186","volume":"17","author":[{"given":"Shirin","family":"Barati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Yadegari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maedeh","family":"Shahmohammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Azami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Tahmasebi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Rouhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Kazemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elmira Roshani","family":"Asl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,5]]},"reference":[{"key":"1884_CR1","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.diabres.2018.02.023","volume":"138","author":"NH Cho","year":"2018","unstructured":"Cho NH, Shaw JE, Karuranga S, Huang Y, da Rocha Fernandes JD, Ohlrogge AW, et al. IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018;138:271\u201381.","journal-title":"Diabetes Res Clin Pract"},{"key":"1884_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s00125-018-4711-2","volume":"62","author":"JL Harding","year":"2019","unstructured":"Harding JL, Pavkov ME, Magliano DJ, Shaw JE, Gregg EW. Global trends in diabetes complications: a review of current evidence. Diabetologia. 2019;62:3\u201316.","journal-title":"Diabetologia"},{"issue":"2","key":"1884_CR3","doi-asserted-by":"publisher","first-page":"126","DOI":"10.14341\/7674","volume":"20","author":"AA Chernikov","year":"2017","unstructured":"Chernikov AA, Severina AS, Shamhalova MS, Shestakova MV. The role of \u00abmetabolic memory\u00bb mechanisms in the development and progression of vascular complications of diabetes mellitus. Diabetes Mellitus. 2017;20(2):126\u201334.","journal-title":"Diabetes Mellitus"},{"issue":"4","key":"1884_CR4","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.numecd.2016.01.006","volume":"26","author":"A Ceriello","year":"2016","unstructured":"Ceriello A, Testa R, Genovese S. Clinical implications of oxidative stress and potential role of natural antioxidants in diabetic vascular complications. Nutr Metabolism Cardiovasc Dis. 2016;26(4):285\u201392.","journal-title":"Nutr Metabolism Cardiovasc Dis"},{"issue":"11","key":"1884_CR5","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.7150\/ijbs.27173","volume":"14","author":"X Huang","year":"2018","unstructured":"Huang X, Liu G, Guo J, Su Z. The PI3K\/AKT pathway in obesity and type 2 diabetes. Int J Biol Sci. 2018;14(11):1483\u201396.","journal-title":"Int J Biol Sci"},{"issue":"4","key":"1884_CR6","first-page":"3073","volume":"22","author":"H Yang","year":"2020","unstructured":"Yang H, Cao Q, Xiong X, Zhao P, Shen D, Zhang Y, et al. Fluoxetine regulates glucose and lipid metabolism via the PI3K\u2013AKT signaling pathway in diabetic rats. Mol Med Rep. 2020;22(4):3073\u201380.","journal-title":"Mol Med Rep"},{"issue":"11","key":"1884_CR7","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1016\/j.bbamcr.2011.03.010","volume":"1813","author":"X Zhang","year":"2011","unstructured":"Zhang X, Tang N, Hadden TJ, Rishi AK, Akt. FoxO and regulation of apoptosis. Biochim Biophys Acta. 2011;1813(11):1978\u201386.","journal-title":"Biochim Biophys Acta"},{"key":"1884_CR8","doi-asserted-by":"crossref","unstructured":"Yung JHM, Giacca A. Role of c-Jun N-terminal kinase (JNK) in obesity and type 2 diabetes. Cells. 2020;9(3).","DOI":"10.3390\/cells9030706"},{"issue":"8","key":"1884_CR9","doi-asserted-by":"publisher","first-page":"1837","DOI":"10.3390\/nu11081837","volume":"11","author":"F Pivari","year":"2019","unstructured":"Pivari F, Mingione A, Brasacchio C, Soldati L. Curcumin and type 2 diabetes mellitus: prevention and treatment. Nutrients. 2019;11(8):1837.","journal-title":"Nutrients"},{"issue":"18","key":"1884_CR10","doi-asserted-by":"publisher","first-page":"2841","DOI":"10.1021\/ol000173t","volume":"2","author":"LR Barclay","year":"2000","unstructured":"Barclay LR, Vinqvist MR, Mukai K, Goto H, Hashimoto Y, Tokunaga A, et al. On the antioxidant mechanism of curcumin: classical methods are needed to determine antioxidant mechanism and activity. Org Lett. 2000;2(18):2841\u20133.","journal-title":"Org Lett"},{"issue":"6","key":"1884_CR11","doi-asserted-by":"publisher","first-page":"3474","DOI":"10.4049\/jimmunol.163.6.3474","volume":"163","author":"C Jobin","year":"1999","unstructured":"Jobin C, Bradham CA, Russo MP, Juma B, Narula AS, Brenner DA, et al. Curcumin blocks cytokine-mediated NF-kappa B activation and Proinflammatory gene expression by inhibiting inhibitory factor I-kappa B kinase activity. J Immunol. 1999;163(6):3474\u201383.","journal-title":"J Immunol"},{"issue":"3","key":"1884_CR12","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.intimp.2006.11.006","volume":"7","author":"L Camacho-Barquero","year":"2007","unstructured":"Camacho-Barquero L, Villegas I, S\u00e1nchez-Calvo JM, Talero E, S\u00e1nchez-Fidalgo S, Motilva V, et al. Curcumin, a curcuma longa constituent, acts on MAPK p38 pathway modulating COX-2 and iNOS expression in chronic experimental colitis. Int Immunopharmacol. 2007;7(3):333\u201342.","journal-title":"Int Immunopharmacol"},{"key":"1884_CR13","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1186\/1472-6882-13-368","volume":"13","author":"SM El-Bahr","year":"2013","unstructured":"El-Bahr SM. Curcumin regulates gene expression of insulin like growth factor, B-cell cll\/lymphoma 2 and antioxidant enzymes in streptozotocin induced diabetic rats. BMC Complement Altern Med. 2013;13:368.","journal-title":"BMC Complement Altern Med"},{"issue":"4","key":"1884_CR14","first-page":"194","volume":"5","author":"YH Aldebasi","year":"2013","unstructured":"Aldebasi YH, Aly SM, Rahmani AH. Therapeutic implications of Curcumin in the prevention of diabetic retinopathy via modulation of anti-oxidant activity and genetic pathways. Int J Physiol Pathophysiol Pharmacol. 2013;5(4):194\u2013202.","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"issue":"5","key":"1884_CR15","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/s00210-011-0624-z","volume":"383","author":"S Nakmareong","year":"2011","unstructured":"Nakmareong S, Kukongviriyapan U, Pakdeechote P, Donpunha W, Kukongviriyapan V, Kongyingyoes B, et al. Antioxidant and vascular protective effects of Curcumin and Tetrahydrocurcumin in rats with L-NAME-induced hypertension. Naunyn Schmiedebergs Arch Pharmacol. 2011;383(5):519\u201329.","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"1","key":"1884_CR16","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1007\/s11033-024-09291-1","volume":"51","author":"Y Rasmi","year":"2024","unstructured":"Rasmi Y, di Bari I, Faisal S, Haque M, Aramwit P, da Silva A, et al. Herbal-based therapeutics for diabetic patients with SARS-Cov-2 infection. Mol Biol Rep. 2024;51(1):316.","journal-title":"Mol Biol Rep"},{"issue":"12","key":"1884_CR17","first-page":"1934578X1000501","volume":"5","author":"K Zandi","year":"2010","unstructured":"Zandi K, Ramedani E, Mohammadi K, Tajbakhsh S, Deilami I, Rastian Z, et al. Evaluation of antiviral activities of Curcumin derivatives against HSV-1 in Vero cell line. Nat Prod Commun. 2010;5(12):1934578X1000501220.","journal-title":"Nat Prod Commun"},{"key":"1884_CR18","unstructured":"Karolin Kamel A-A. Comparative evaluation of the anti-ulcer activity of curcumin and omeprazole during the acute phase of gastric ulcer\u2014efficacy of curcumin in gastric ulcer prevention against omeprazole. Food and Nutrition Sciences. 2011;2011."},{"issue":"3","key":"1884_CR19","doi-asserted-by":"publisher","first-page":"e59843","DOI":"10.1371\/journal.pone.0059843","volume":"8","author":"J Wu","year":"2013","unstructured":"Wu J, Li Q, Wang X, Yu S, Li L, Wu X, et al. Neuroprotection by Curcumin in ischemic brain injury involves the Akt\/Nrf2 pathway. PLoS ONE. 2013;8(3):e59843.","journal-title":"PLoS ONE"},{"issue":"4","key":"1884_CR20","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1002\/jcb.23019","volume":"112","author":"S Liao","year":"2011","unstructured":"Liao S, Xia J, Chen Z, Zhang S, Ahmad A, Miele L, et al. Inhibitory effect of Curcumin on oral carcinoma CAL-27 cells via suppression of Notch\u20101 and NF\u2010\u03baB signaling pathways. J Cell Biochem. 2011;112(4):1055\u201365.","journal-title":"J Cell Biochem"},{"issue":"4","key":"1884_CR21","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/j.fct.2007.09.095","volume":"46","author":"EO Farombi","year":"2008","unstructured":"Farombi EO, Shrotriya S, Na H-K, Kim S-H, Surh Y-J. Curcumin attenuates dimethylnitrosamine-induced liver injury in rats through Nrf2-mediated induction of Heme oxygenase-1. Food Chem Toxicol. 2008;46(4):1279\u201387.","journal-title":"Food Chem Toxicol"},{"issue":"8","key":"1884_CR22","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1038\/sj.onc.1207284","volume":"23","author":"D Chendil","year":"2004","unstructured":"Chendil D, Ranga RS, Meigooni D, Sathishkumar S, Ahmed MM. Curcumin confers radiosensitizing effect in prostate cancer cell line PC-3. Oncogene. 2004;23(8):1599\u2013607.","journal-title":"Oncogene"},{"issue":"2","key":"1884_CR23","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1089\/ars.2008.2140","volume":"11","author":"SK Jain","year":"2009","unstructured":"Jain SK, Rains J, Croad J, Larson B, Jones K. Curcumin supplementation lowers TNF-alpha, IL-6, IL-8, and MCP-1 secretion in high glucose-treated cultured monocytes and blood levels of TNF-alpha, IL-6, MCP-1, glucose, and glycosylated hemoglobin in diabetic rats. Antioxid Redox Signal. 2009;11(2):241\u20139.","journal-title":"Antioxid Redox Signal"},{"issue":"6","key":"1884_CR24","doi-asserted-by":"publisher","first-page":"8289","DOI":"10.3390\/molecules19068289","volume":"19","author":"LM Jim\u00e9nez-Flores","year":"2014","unstructured":"Jim\u00e9nez-Flores LM, L\u00f3pez-Briones S, Mac\u00edas-Cervantes MH, Ram\u00edrez-Emiliano J, P\u00e9rez-V\u00e1zquez VA, PPAR\u03b3. NF-\u03baB and AMPK-dependent mechanism May be involved in the beneficial effects of Curcumin in the diabetic db\/db mice liver. Molecules. 2014;19(6):8289\u2013302.","journal-title":"Molecules"},{"key":"1884_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1743-7075-5-17","volume":"5","author":"AM Gonzales","year":"2008","unstructured":"Gonzales AM, Orlando RA. Curcumin and Resveratrol inhibit nuclear factor-kappaB-mediated cytokine expression in adipocytes. Nutr Metab (Lond). 2008;5:17.","journal-title":"Nutr Metab (Lond)"},{"issue":"4","key":"1884_CR26","first-page":"346","volume":"12","author":"M Atabaki","year":"2022","unstructured":"Atabaki M, Shariati-Sarabi Z, Tavakkol-Afshari J, Taghipour A, Jafari MR, Nikpoor AR, et al. Curcumin as an effective suppressor of MiRNA expression in patients with knee osteoarthritis. Avicenna J Phytomedicine. 2022;12(4):346.","journal-title":"Avicenna J Phytomedicine"},{"issue":"3","key":"1884_CR27","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1042\/BSR20100065","volume":"31","author":"G Mudduluru","year":"2011","unstructured":"Mudduluru G, George-William JN, Muppala S, Asangani IA, Kumarswamy R, Nelson LD, et al. Curcumin regulates miR-21 expression and inhibits invasion and metastasis in colorectal cancer. Biosci Rep. 2011;31(3):185\u201397.","journal-title":"Biosci Rep"},{"issue":"1","key":"1884_CR28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s10654-015-0094-6","volume":"31","author":"R Hanewinckel","year":"2016","unstructured":"Hanewinckel R, van Oijen M, Ikram MA, van Doorn PA. The epidemiology and risk factors of chronic polyneuropathy. Eur J Epidemiol. 2016;31(1):5\u201320.","journal-title":"Eur J Epidemiol"},{"issue":"6","key":"1884_CR29","doi-asserted-by":"publisher","first-page":"1790","DOI":"10.2337\/diacare.26.6.1790","volume":"26","author":"A Gordois","year":"2003","unstructured":"Gordois A, Scuffham P, Shearer A, Oglesby A, Tobian JA. The health care costs of diabetic peripheral neuropathy in the US. Diabetes Care. 2003;26(6):1790\u20135.","journal-title":"Diabetes Care"},{"key":"1884_CR30","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.diabres.2018.08.020","volume":"144","author":"G Sloan","year":"2018","unstructured":"Sloan G, Shillo P, Selvarajah D, Wu J, Wilkinson ID, Tracey I, et al. A new look at painful diabetic neuropathy. Diabetes Res Clin Pract. 2018;144:177\u201391.","journal-title":"Diabetes Res Clin Pract"},{"issue":"4","key":"1884_CR31","doi-asserted-by":"publisher","first-page":"645","DOI":"10.2337\/dc17-1836","volume":"41","author":"WJ Jeffcoate","year":"2018","unstructured":"Jeffcoate WJ, Vileikyte L, Boyko EJ, Armstrong DG, Boulton AJM. Current challenges and opportunities in the prevention and management of diabetic foot ulcers. Diabetes Care. 2018;41(4):645\u201352.","journal-title":"Diabetes Care"},{"key":"1884_CR32","doi-asserted-by":"crossref","unstructured":"Boulton AJM, Armstrong DG, Kirsner RS, Attinger CE, Lavery LA, Lipsky BA, et al. ADA clinical compendia series. Diagnosis and management of diabetic foot complications. Arlington (VA). American diabetes association \u00a9 2018 by American diabetes association. All rights reserved. None of the contents may be reproduced without the written permission of the American Diabetes Association.; 2018.","DOI":"10.2337\/db20182-1"},{"issue":"4","key":"1884_CR33","doi-asserted-by":"publisher","first-page":"s511","DOI":"10.1093\/advances\/nmy023","volume":"9","author":"JW Miller","year":"2018","unstructured":"Miller JW, Proton P, Inhibitors. H2-Receptor antagonists, metformin, and vitamin B-12 deficiency: clinical implications. Adv Nutr. 2018;9(4):s511\u20138.","journal-title":"Adv Nutr"},{"issue":"8","key":"1884_CR34","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1111\/dom.14734","volume":"24","author":"DSH Bell","year":"2022","unstructured":"Bell DSH. Metformin-induced vitamin B12 deficiency can cause or worsen distal symmetrical, autonomic and cardiac neuropathy in the patient with diabetes. Diabetes Obes Metab. 2022;24(8):1423\u20138.","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"1884_CR35","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.cmet.2018.08.014","volume":"28","author":"J Chaudhuri","year":"2018","unstructured":"Chaudhuri J, Bains Y, Guha S, Kahn A, Hall D, Bose N, et al. The role of advanced glycation end products in aging and metabolic diseases: bridging association and causality. Cell Metab. 2018;28(3):337\u201352.","journal-title":"Cell Metab"},{"issue":"13\u201315","key":"1884_CR36","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1089\/ars.2022.0158","volume":"38","author":"J Enders","year":"2023","unstructured":"Enders J, Elliott D, Wright DE. Emerging nonpharmacologic interventions to treat diabetic peripheral neuropathy. Antioxid Redox Signal. 2023;38(13\u201315):989\u20131000.","journal-title":"Antioxid Redox Signal"},{"issue":"7","key":"1884_CR37","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/s41574-021-00496-z","volume":"17","author":"G Sloan","year":"2021","unstructured":"Sloan G, Selvarajah D, Tesfaye S. Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy. Nat Rev Endocrinol. 2021;17(7):400\u201320.","journal-title":"Nat Rev Endocrinol"},{"key":"1884_CR38","doi-asserted-by":"publisher","first-page":"m997","DOI":"10.1136\/bmj.m997","volume":"369","author":"Y Li","year":"2020","unstructured":"Li Y, Teng D, Shi X, Qin G, Qin Y, Quan H, et al. Prevalence of diabetes recorded in Mainland China using 2018 diagnostic criteria from the American diabetes association: National cross sectional study. BMJ. 2020;369:m997.","journal-title":"BMJ"},{"key":"1884_CR39","doi-asserted-by":"publisher","first-page":"l1108","DOI":"10.1136\/bmj.l1108","volume":"365","author":"KG Gwathmey","year":"2019","unstructured":"Gwathmey KG, Pearson KT. Diagnosis and management of sensory polyneuropathy. BMJ. 2019;365:l1108.","journal-title":"BMJ"},{"issue":"3","key":"1884_CR40","doi-asserted-by":"publisher","first-page":"e58783","DOI":"10.1371\/journal.pone.0058783","volume":"8","author":"A Weisman","year":"2013","unstructured":"Weisman A, Bril V, Ngo M, Lovblom LE, Halpern EM, Orszag A, et al. Identification and prediction of diabetic sensorimotor polyneuropathy using individual and simple combinations of nerve conduction study parameters. PLoS ONE. 2013;8(3):e58783.","journal-title":"PLoS ONE"},{"key":"1884_CR41","doi-asserted-by":"publisher","first-page":"617","DOI":"10.3389\/fendo.2018.00617","volume":"9","author":"Q Pan","year":"2018","unstructured":"Pan Q, Li Q, Deng W, Zhao D, Qi L, Huang W, et al. Prevalence of and risk factors for peripheral neuropathy in Chinese patients with diabetes: A multicenter Cross-Sectional study. Front Endocrinol (Lausanne). 2018;9:617.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1884_CR42","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.3389\/fnins.2019.01144","volume":"13","author":"Q Pan","year":"2019","unstructured":"Pan Q, Li Q, Deng W, Zhao D, Qi L, Huang W, et al. Prevalence and diagnosis of diabetic cardiovascular autonomic neuropathy in beijing, china: A retrospective multicenter clinical study. Front Neurosci. 2019;13:1144.","journal-title":"Front Neurosci"},{"issue":"1","key":"1884_CR43","doi-asserted-by":"publisher","first-page":"e32653","DOI":"10.1097\/MD.0000000000032653","volume":"102","author":"J Li","year":"2023","unstructured":"Li J, Guan R, Pan L. Mechanism of Schwann cells in diabetic peripheral neuropathy: A review. Med (Baltim). 2023;102(1):e32653.","journal-title":"Med (Baltim)"},{"issue":"10","key":"1884_CR44","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1016\/S1474-4422(22)00188-0","volume":"21","author":"MA Elafros","year":"2022","unstructured":"Elafros MA, Andersen H, Bennett DL, Savelieff MG, Viswanathan V, Callaghan BC, et al. Towards prevention of diabetic peripheral neuropathy: clinical presentation, pathogenesis, and new treatments. Lancet Neurol. 2022;21(10):922\u201336.","journal-title":"Lancet Neurol"},{"issue":"Suppl 1","key":"1884_CR45","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1093\/pm\/pnaa164","volume":"21","author":"T Lin","year":"2020","unstructured":"Lin T, Gargya A, Singh H, Sivanesan E, Gulati A. Mechanism of peripheral nerve stimulation in chronic pain. Pain Med. 2020;21(Suppl 1):S6\u201312.","journal-title":"Pain Med"},{"key":"1884_CR46","doi-asserted-by":"publisher","first-page":"105952","DOI":"10.1016\/j.nbd.2022.105952","volume":"176","author":"M Bosch-Queralt","year":"2023","unstructured":"Bosch-Queralt M, Fledrich R, Stassart RM. Schwann cell functions in peripheral nerve development and repair. Neurobiol Dis. 2023;176:105952.","journal-title":"Neurobiol Dis"},{"issue":"4","key":"1884_CR47","doi-asserted-by":"publisher","first-page":"2156","DOI":"10.1007\/s13311-021-01080-z","volume":"18","author":"SC Previtali","year":"2021","unstructured":"Previtali SC. Peripheral nerve development and the pathogenesis of peripheral neuropathy: the sorting point. Neurotherapeutics. 2021;18(4):2156\u201368.","journal-title":"Neurotherapeutics"},{"issue":"Suppl 2","key":"1884_CR48","first-page":"S11","volume":"26","author":"A Hoke","year":"2021","unstructured":"Hoke A, Cerri F, Fisgin A, Riva N, Quattrini A. Normal structure and pathological features in peripheral neuropathies. J Peripher Nerv Syst. 2021;26(Suppl 2):S11\u201320.","journal-title":"J Peripher Nerv Syst"},{"issue":"7","key":"1884_CR49","doi-asserted-by":"publisher","first-page":"8008","DOI":"10.1096\/fj.201900127R","volume":"33","author":"W Du","year":"2019","unstructured":"Du W, Wang N, Li F, Jia K, An J, Liu Y, et al. STAT3 phosphorylation mediates high glucose-impaired cell autophagy in an HDAC1-dependent and -independent manner in Schwann cells of diabetic peripheral neuropathy. Faseb J. 2019;33(7):8008\u201321.","journal-title":"Faseb J"},{"key":"1884_CR50","doi-asserted-by":"publisher","first-page":"117459","DOI":"10.1016\/j.lfs.2020.117459","volume":"248","author":"YP Liu","year":"2020","unstructured":"Liu YP, Shao SJ, Guo HD. Schwann cells apoptosis is induced by high glucose in diabetic peripheral neuropathy. Life Sci. 2020;248:117459.","journal-title":"Life Sci"},{"key":"1884_CR51","doi-asserted-by":"publisher","first-page":"154867","DOI":"10.1016\/j.metabol.2021.154867","volume":"123","author":"S Cernea","year":"2021","unstructured":"Cernea S, Raz I. Management of diabetic neuropathy. Metabolism. 2021;123:154867.","journal-title":"Metabolism"},{"key":"1884_CR52","doi-asserted-by":"publisher","first-page":"5345269","DOI":"10.1155\/2022\/5345269","volume":"2022","author":"J Shen","year":"2022","unstructured":"Shen J. Plasticity of the central nervous system involving peripheral nerve transfer. Neural Plast. 2022;2022:5345269.","journal-title":"Neural Plast"},{"issue":"6","key":"1884_CR53","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1016\/j.neuron.2017.02.005","volume":"93","author":"EL Feldman","year":"2017","unstructured":"Feldman EL, Nave KA, Jensen TS, Bennett DLH. New horizons in diabetic neuropathy: mechanisms, bioenergetics, and pain. Neuron. 2017;93(6):1296\u2013313.","journal-title":"Neuron"},{"issue":"Suppl 1","key":"1884_CR54","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1097\/j.pain.0000000000001528","volume":"160","author":"A DiAntonio","year":"2019","unstructured":"DiAntonio A. Axon degeneration: mechanistic insights lead to therapeutic opportunities for the prevention and treatment of peripheral neuropathy. Pain. 2019;160(Suppl 1):S17\u201322.","journal-title":"Pain"},{"issue":"5","key":"1884_CR55","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1002\/jnr.24538","volume":"98","author":"M Modrak","year":"2020","unstructured":"Modrak M, Talukder MAH, Gurgenashvili K, Noble M, Elfar JC. Peripheral nerve injury and myelination: potential therapeutic strategies. J Neurosci Res. 2020;98(5):780\u201395.","journal-title":"J Neurosci Res"},{"key":"1884_CR56","doi-asserted-by":"crossref","unstructured":"Mrowicka M, Mrowicki J, Majsterek I. Relationship between biochemical pathways and non-coding RNAs involved in the progression of diabetic retinopathy. J Clin Med. 2024;13(1).","DOI":"10.3390\/jcm13010292"},{"key":"1884_CR57","unstructured":"Anandhanarayanan A, Teh K, Goonoo M, Tesfaye S, Selvarajah D. Diabetic neuropathies. Endotext [Internet]; 2022."},{"issue":"1","key":"1884_CR58","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1001\/jama.2023.10578","volume":"330","author":"DG Armstrong","year":"2023","unstructured":"Armstrong DG, Tan TW, Boulton AJM, Bus SA. Diabetic foot ulcers: A review. JAMA. 2023;330(1):62\u201375.","journal-title":"JAMA"},{"issue":"1","key":"1884_CR59","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1038\/s41392-025-02175-1","volume":"10","author":"Y Yang","year":"2025","unstructured":"Yang Y, Zhao B, Wang Y, Lan H, Liu X, Hu Y, et al. Diabetic neuropathy: cutting-edge research and future directions. Signal Transduct Target Ther. 2025;10(1):132.","journal-title":"Signal Transduct Target Ther"},{"key":"1884_CR60","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez P, Lozano P, Ros G, Solano F. Hyperglycemia and oxidative stress: an integral, updated and critical overview of their metabolic interconnections. Int J Mol Sci. 2023;24(11).","DOI":"10.3390\/ijms24119352"},{"issue":"2","key":"1884_CR61","first-page":"19","volume":"26","author":"G Wilcox","year":"2005","unstructured":"Wilcox G. Insulin and insulin resistance. Clin Biochemist Reviews. 2005;26(2):19.","journal-title":"Clin Biochemist Reviews"},{"issue":"2","key":"1884_CR62","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/nm1166","volume":"11","author":"D Cai","year":"2005","unstructured":"Cai D, Yuan M, Frantz DF, Melendez PA, Hansen L, Lee J, et al. Local and systemic insulin resistance resulting from hepatic activation of IKK-\u03b2 and NF-\u03baB. Nat Med. 2005;11(2):183\u201390.","journal-title":"Nat Med"},{"key":"1884_CR63","doi-asserted-by":"publisher","first-page":"117045","DOI":"10.1016\/j.lfs.2019.117045","volume":"239","author":"MA Ibrahim","year":"2019","unstructured":"Ibrahim MA, Isah MS, Ibrahim S. Inhibition of JAK-STAT and NF-\u03baB signalling systems could be a novel therapeutic target against insulin resistance and type 2 diabetes. Life Sci. 2019;239:117045.","journal-title":"Life Sci"},{"key":"1884_CR64","doi-asserted-by":"publisher","first-page":"1265372","DOI":"10.3389\/fendo.2023.1265372","volume":"14","author":"J Zhu","year":"2023","unstructured":"Zhu J, Hu Z, Luo Y, Liu Y, Luo W, Du X, et al. Diabetic peripheral neuropathy: pathogenetic mechanisms and treatment. Front Endocrinol (Lausanne). 2023;14:1265372.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"1884_CR65","doi-asserted-by":"publisher","first-page":"E156","DOI":"10.1152\/ajpendo.00642.2020","volume":"321","author":"R Agrawal","year":"2021","unstructured":"Agrawal R, Reno CM, Sharma S, Christensen C, Huang Y, Fisher SJ. Insulin action in the brain regulates both central and peripheral functions. Am J Physiol Endocrinol Metab. 2021;321(1):E156\u201363.","journal-title":"Am J Physiol Endocrinol Metab"},{"issue":"3","key":"1884_CR66","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.tem.2011.12.004","volume":"23","author":"B Kim","year":"2012","unstructured":"Kim B, Feldman EL. Insulin resistance in the nervous system. Trends Endocrinol Metab. 2012;23(3):133\u201341.","journal-title":"Trends Endocrinol Metab"},{"key":"1884_CR67","doi-asserted-by":"crossref","unstructured":"Boucher J, Kleinridders A, Kahn CR. Insulin receptor signaling in normal and insulin-resistant States. Cold Spring Harb Perspect Biol. 2014;6(1).","DOI":"10.1101\/cshperspect.a009191"},{"issue":"30","key":"1884_CR68","doi-asserted-by":"publisher","first-page":"6724","DOI":"10.1523\/JNEUROSCI.5520-03.2004","volume":"24","author":"T Ogata","year":"2004","unstructured":"Ogata T, Iijima S, Hoshikawa S, Miura T, Yamamoto S, Oda H, et al. Opposing extracellular signal-regulated kinase and Akt pathways control Schwann cell myelination. J Neurosci. 2004;24(30):6724\u201332.","journal-title":"J Neurosci"},{"key":"1884_CR69","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.expneurol.2017.08.005","volume":"297","author":"MR Aghanoori","year":"2017","unstructured":"Aghanoori MR, Smith DR, Roy Chowdhury S, Sabbir MG, Calcutt NA, Fernyhough P. Insulin prevents aberrant mitochondrial phenotype in sensory neurons of type 1 diabetic rats. Exp Neurol. 2017;297:148\u201357.","journal-title":"Exp Neurol"},{"key":"1884_CR70","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/2051-5960-1-15","volume":"1","author":"CW Grote","year":"2013","unstructured":"Grote CW, Groover AL, Ryals JM, Geiger PC, Feldman EL, Wright DE. Peripheral nervous system insulin resistance in ob\/ob mice. Acta Neuropathol Commun. 2013;1:15.","journal-title":"Acta Neuropathol Commun"},{"issue":"4","key":"1884_CR71","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/j.mcna.2004.04.001","volume":"88","author":"AJ Garber","year":"2004","unstructured":"Garber AJ. The metabolic syndrome. Med Clin North Am. 2004;88(4):837\u201346. ix.","journal-title":"Med Clin North Am"},{"issue":"1\u20132","key":"1884_CR72","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.mce.2005.12.014","volume":"246","author":"D Dey","year":"2006","unstructured":"Dey D, Basu D, Roy SS, Bandyopadhyay A, Bhattacharya S. Involvement of novel PKC isoforms in FFA induced defects in insulin signaling. Mol Cell Endocrinol. 2006;246(1\u20132):60\u20134.","journal-title":"Mol Cell Endocrinol"},{"issue":"10","key":"1884_CR73","doi-asserted-by":"publisher","first-page":"2929","DOI":"10.2337\/diabetes.51.10.2929","volume":"51","author":"HH Zhang","year":"2002","unstructured":"Zhang HH, Halbleib M, Ahmad F, Manganiello VC, Greenberg AS. Tumor necrosis factor-alpha stimulates lipolysis in differentiated human adipocytes through activation of extracellular signal-related kinase and elevation of intracellular cAMP. Diabetes. 2002;51(10):2929\u201335.","journal-title":"Diabetes"},{"key":"1884_CR74","doi-asserted-by":"crossref","unstructured":"A ISS, C AB. A JS. Changes in plasma free fatty acids associated with Type-2 diabetes. Nutrients. 2019;11(9).","DOI":"10.3390\/nu11092022"},{"key":"1884_CR75","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.abb.2019.02.008","volume":"670","author":"JM Platnich","year":"2019","unstructured":"Platnich JM, Muruve DA. NOD-like receptors and inflammasomes: A review of their canonical and non-canonical signaling pathways. Arch Biochem Biophys. 2019;670:4\u201314.","journal-title":"Arch Biochem Biophys"},{"issue":"9","key":"1884_CR76","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.1210\/jc.2016-2030","volume":"101","author":"M Roustit","year":"2016","unstructured":"Roustit M, Loader J, Deusenbery C, Baltzis D, Veves A. Endothelial dysfunction as a link between cardiovascular risk factors and peripheral neuropathy in diabetes. J Clin Endocrinol Metab. 2016;101(9):3401\u20138.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1884_CR77","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1038\/nri2925","volume":"11","author":"MY Donath","year":"2011","unstructured":"Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol. 2011;11(2):98\u2013107.","journal-title":"Nat Rev Immunol"},{"issue":"5907","key":"1884_CR78","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1126\/science.1160794","volume":"322","author":"G Sabio","year":"2008","unstructured":"Sabio G, Das M, Mora A, Zhang Z, Jun JY, Ko HJ, et al. A stress signaling pathway in adipose tissue regulates hepatic insulin resistance. Science. 2008;322(5907):1539\u201343.","journal-title":"Science"},{"key":"1884_CR79","doi-asserted-by":"publisher","first-page":"102179","DOI":"10.1016\/j.npep.2021.102179","volume":"89","author":"F Tahmasebi","year":"2021","unstructured":"Tahmasebi F, Barati S, Kashani IR. Effect of CSF1R inhibitor on glial cells population and remyelination in the Cuprizone model. Neuropeptides. 2021;89:102179.","journal-title":"Neuropeptides"},{"issue":"4","key":"1884_CR80","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s00424-019-02262-7","volume":"471","author":"IM Al-Amily","year":"2019","unstructured":"Al-Amily IM, Dun\u00e9r P, Groop L, Salehi A. The functional impact of G protein-coupled receptor 142 (Gpr142) on pancreatic \u03b2-cell in rodent. Pflugers Arch. 2019;471(4):633\u201345.","journal-title":"Pflugers Arch"},{"issue":"7418","key":"1884_CR81","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nature11351","volume":"490","author":"J von Moltke","year":"2012","unstructured":"von Moltke J, Trinidad NJ, Moayeri M, Kintzer AF, Wang SB, van Rooijen N, et al. Rapid induction of inflammatory lipid mediators by the inflammasome in vivo. Nature. 2012;490(7418):107\u201311.","journal-title":"Nature"},{"issue":"7","key":"1884_CR82","doi-asserted-by":"publisher","first-page":"2231","DOI":"10.1210\/jc.2011-3408","volume":"97","author":"C Piperi","year":"2012","unstructured":"Piperi C, Adamopoulos C, Dalagiorgou G, Diamanti-Kandarakis E, Papavassiliou AG. Crosstalk between advanced glycation and Endoplasmic reticulum stress: emerging therapeutic targeting for metabolic diseases. J Clin Endocrinol Metabolism. 2012;97(7):2231\u201342.","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"4","key":"1884_CR83","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/j.kint.2017.11.034","volume":"93","author":"N Rabbani","year":"2018","unstructured":"Rabbani N, Thornalley PJ. Advanced glycation end products in the pathogenesis of chronic kidney disease. Kidney Int. 2018;93(4):803\u201313.","journal-title":"Kidney Int"},{"key":"1884_CR84","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13020-017-0134-0","volume":"12","author":"J-N Hong","year":"2017","unstructured":"Hong J-N, Li W-W, Wang L-L, Guo H, Jiang Y, Gao Y-J, et al. Jiangtang Decoction ameliorate diabetic nephropathy through the regulation of PI3K\/Akt-mediated NF-\u03baB pathways in KK-Ay mice. Chin Med. 2017;12:1\u201316.","journal-title":"Chin Med"},{"key":"1884_CR85","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.ejphar.2018.06.001","volume":"833","author":"D Sanajou","year":"2018","unstructured":"Sanajou D, Haghjo AG, Argani H, Aslani S. AGE-RAGE axis Blockade in diabetic nephropathy: current status and future directions. Eur J Pharmacol. 2018;833:158\u201364.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"1884_CR86","first-page":"6823058","volume":"2018","author":"Y-H Chen","year":"2018","unstructured":"Chen Y-H, Chen Z-W, Li H-M, Yan X-F, Feng B. AGE\/RAGE-induced EMP release via the NOX\u2010derived ROS pathway. J Diabetes Res. 2018;2018(1):6823058.","journal-title":"J Diabetes Res"},{"key":"1884_CR87","doi-asserted-by":"crossref","unstructured":"Rouhiainen A, Kuja-Panula J, Tumova S, Rauvala H. RAGE-mediated cell signaling. Calcium-binding proteins and RAGE: From structural basics to clinical applications. 2013:239\u2013\u200963.","DOI":"10.1007\/978-1-62703-230-8_15"},{"issue":"2","key":"1884_CR88","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41419-017-0135-z","volume":"9","author":"CMO Volpe","year":"2018","unstructured":"Volpe CMO, Villar-Delfino PH, Dos Anjos PMF, Nogueira-Machado JA. Cellular death, reactive oxygen species (ROS) and diabetic complications. Cell Death Dis. 2018;9(2):119.","journal-title":"Cell Death Dis"},{"issue":"1","key":"1884_CR89","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4062\/biomolther.2019.188","volume":"28","author":"SR Lee","year":"2020","unstructured":"Lee SR, An EJ, Kim J, Bae YS. Function of NADPH oxidases in diabetic nephropathy and development of nox inhibitors. Biomolecules Ther. 2020;28(1):25.","journal-title":"Biomolecules Ther"},{"issue":"6","key":"1884_CR90","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1681\/ASN.2013070810","volume":"25","author":"JC Jha","year":"2014","unstructured":"Jha JC, Gray SP, Barit D, Okabe J, El-Osta A, Namikoshi T, et al. Genetic targeting or Pharmacologic Inhibition of NADPH oxidase nox4 provides renoprotection in long-term diabetic nephropathy. J Am Soc Nephrol. 2014;25(6):1237\u201354.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"1884_CR91","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/13813455.2020.1797106","volume":"129","author":"K Parwani","year":"2023","unstructured":"Parwani K, Mandal P. Role of advanced glycation end products and insulin resistance in diabetic nephropathy. Arch Physiol Biochem. 2023;129(1):95\u2013107.","journal-title":"Arch Physiol Biochem"},{"key":"1884_CR92","doi-asserted-by":"crossref","unstructured":"Asiri MMH, Engelsman S, Eijkelkamp N, H\u00f6ppener JWM. Amyloid proteins and peripheral neuropathy. Cells. 2020;9(6).","DOI":"10.3390\/cells9061553"},{"key":"1884_CR93","doi-asserted-by":"crossref","unstructured":"Kawano T, Inokuchi J, Eto M, Murata M, Kang JH. Activators and inhibitors of protein kinase C (PKC): their applications in clinical trials. Pharmaceutics. 2021;13(11).","DOI":"10.3390\/pharmaceutics13111748"},{"issue":"5","key":"1884_CR94","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.cmet.2012.04.002","volume":"15","author":"JA Chavez","year":"2012","unstructured":"Chavez JA, Summers SA. A ceramide-centric view of insulin resistance. Cell Metab. 2012;15(5):585\u201394.","journal-title":"Cell Metab"},{"issue":"1","key":"1884_CR95","doi-asserted-by":"publisher","first-page":"8109","DOI":"10.1038\/s41598-018-26482-6","volume":"8","author":"DC Pinto-Junior","year":"2018","unstructured":"Pinto-Junior DC, Silva KS, Michalani ML, Yonamine CY, Esteves JV, Fabre NT, et al. Advanced glycation end products-induced insulin resistance involves repression of skeletal muscle GLUT4 expression. Sci Rep. 2018;8(1):8109.","journal-title":"Sci Rep"},{"issue":"1","key":"1884_CR96","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jtos.2017.10.006","volume":"16","author":"M Markoulli","year":"2018","unstructured":"Markoulli M, Flanagan J, Tummanapalli SS, Wu J, Willcox M. The impact of diabetes on corneal nerve morphology and ocular surface integrity. Ocul Surf. 2018;16(1):45\u201357.","journal-title":"Ocul Surf"},{"key":"1884_CR97","doi-asserted-by":"publisher","first-page":"655591","DOI":"10.3389\/fendo.2021.655591","volume":"12","author":"X Wang","year":"2021","unstructured":"Wang X, Li Q, Han X, Gong M, Yu Z, Xu B. Electroacupuncture alleviates diabetic peripheral neuropathy by regulating Glycolipid-Related glo\/ages\/rage axis. Front Endocrinol (Lausanne). 2021;12:655591.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"1884_CR98","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.3892\/mmr.2014.2888","volume":"11","author":"J Fang","year":"2015","unstructured":"Fang J, Zhou S-H, Fan J, Yan S-X. Roles of glucose transporter-1 and the phosphatidylinositol 3\u2013kinase\/protein kinase B pathway in cancer radioresistance. Mol Med Rep. 2015;11(3):1573\u201381.","journal-title":"Mol Med Rep"},{"issue":"11","key":"1884_CR99","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.7150\/ijbs.27173","volume":"14","author":"X Huang","year":"2018","unstructured":"Huang X, Liu G, Guo J, Su Z. The PI3K\/AKT pathway in obesity and type 2 diabetes. Int J Biol Sci. 2018;14(11):1483.","journal-title":"Int J Biol Sci"},{"issue":"9","key":"1884_CR100","doi-asserted-by":"publisher","first-page":"856","DOI":"10.3390\/metabo12090856","volume":"12","author":"S-Y Feng","year":"2022","unstructured":"Feng S-Y, Wu S-J, Chang Y-C, Ng L-T, Chang S-J. Stimulation of GLUT4 glucose uptake by anthocyanin-rich extract from black rice (Oryza sativa L.) via PI3K\/Akt and AMPK\/p38 MAPK signaling in C2C12 cells. Metabolites. 2022;12(9):856.","journal-title":"Metabolites"},{"issue":"3","key":"1884_CR101","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1038\/nrm3757","volume":"15","author":"M Shimobayashi","year":"2014","unstructured":"Shimobayashi M, Hall MN. Making new contacts: the mTOR network in metabolism and signalling crosstalk. Nat Rev Mol Cell Biol. 2014;15(3):155\u201362.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"1884_CR102","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.cmet.2017.11.004","volume":"27","author":"A Ardestani","year":"2018","unstructured":"Ardestani A, Lupse B, Kido Y, Leibowitz G, Maedler K. mTORC1 signaling: A Double-Edged sword in diabetic \u03b2 cells. Cell Metab. 2018;27(2):314\u201331.","journal-title":"Cell Metab"},{"issue":"7","key":"1884_CR103","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1172\/JCI22098","volume":"114","author":"S Georgia","year":"2004","unstructured":"Georgia S, Bhushan A. Beta cell replication is the primary mechanism for maintaining postnatal beta cell mass. J Clin Invest. 2004;114(7):963\u20138.","journal-title":"J Clin Invest"},{"issue":"7","key":"1884_CR104","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1002\/iub.1293","volume":"66","author":"J Zhang","year":"2014","unstructured":"Zhang J, Liu F. Tissue-specific insulin signaling in the regulation of metabolism and aging. IUBMB Life. 2014;66(7):485\u201395.","journal-title":"IUBMB Life"},{"key":"1884_CR105","doi-asserted-by":"publisher","first-page":"3773","DOI":"10.1038\/ncomms4773","volume":"5","author":"SM Bartell","year":"2014","unstructured":"Bartell SM, Kim HN, Ambrogini E, Han L, Iyer S, Serra Ucer S, et al. FoxO proteins restrain osteoclastogenesis and bone resorption by attenuating H2O2 accumulation. Nat Commun. 2014;5:3773.","journal-title":"Nat Commun"},{"issue":"7","key":"1884_CR106","doi-asserted-by":"publisher","first-page":"815","DOI":"10.7150\/ijbs.20052","volume":"13","author":"M Farhan","year":"2017","unstructured":"Farhan M, Wang H, Gaur U, Little PJ, Xu J, Zheng W. FOXO signaling pathways as therapeutic targets in cancer. Int J Biol Sci. 2017;13(7):815\u201327.","journal-title":"Int J Biol Sci"},{"issue":"11","key":"1884_CR107","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1016\/j.metabol.2015.08.011","volume":"64","author":"MP Sajan","year":"2015","unstructured":"Sajan MP, Ivey RA III, Farese RV. BMI-related progression of atypical PKC-dependent aberrations in insulin signaling through IRS-1, akt, FoxO1 and PGC-1\u03b1 in livers of obese and type 2 diabetic humans. Metabolism. 2015;64(11):1454\u201365.","journal-title":"Metabolism"},{"issue":"15","key":"1884_CR108","doi-asserted-by":"publisher","first-page":"10105","DOI":"10.1074\/jbc.M600272200","volume":"281","author":"W Zhang","year":"2006","unstructured":"Zhang W, Patil S, Chauhan B, Guo S, Powell DR, Le J, et al. FoxO1 regulates multiple metabolic pathways in the liver: effects on gluconeogenic, glycolytic, and lipogenic gene expression. J Biol Chem. 2006;281(15):10105\u201317.","journal-title":"J Biol Chem"},{"issue":"4","key":"1884_CR109","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.cell.2017.09.045","volume":"171","author":"F Langlet","year":"2017","unstructured":"Langlet F, Haeusler RA, Lind\u00e9n D, Ericson E, Norris T, Johansson A, et al. Selective Inhibition of FOXO1 activator\/repressor balance modulates hepatic glucose handling. Cell. 2017;171(4):824\u201335. e18.","journal-title":"Cell"},{"issue":"9","key":"1884_CR110","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1111\/j.1365-2443.2012.01625.x","volume":"17","author":"S Miyazaki","year":"2012","unstructured":"Miyazaki S, Minamida R, Furuyama T, Tashiro F, Yamato E, Inagaki S, et al. Analysis of Foxo1-regulated genes using Foxo1\u2010deficient pancreatic \u03b2 cells. Genes Cells. 2012;17(9):758\u201367.","journal-title":"Genes Cells"},{"issue":"1","key":"1884_CR111","doi-asserted-by":"publisher","first-page":"29652","DOI":"10.3402\/fnr.v59.29652","volume":"59","author":"B-Q Xu","year":"2015","unstructured":"Xu B-Q, Yang P, Zhang Y-Q. Hypoglycemic activities of lyophilized powder of Gynura divaricata by improving antioxidant potential and insulin signaling in type 2 diabetic mice. Food Nutr Res. 2015;59(1):29652.","journal-title":"Food Nutr Res"},{"issue":"5","key":"1884_CR112","doi-asserted-by":"publisher","first-page":"2896","DOI":"10.1074\/jbc.M208359200","volume":"278","author":"YH Lee","year":"2003","unstructured":"Lee YH, Giraud J, Davis RJ, White MF. c-Jun N-terminal kinase (JNK) mediates feedback Inhibition of the insulin signaling cascade. J Biol Chem. 2003;278(5):2896\u2013902.","journal-title":"J Biol Chem"},{"issue":"12","key":"1884_CR113","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1002\/oby.20410","volume":"21","author":"BM Carvalho","year":"2013","unstructured":"Carvalho BM, Oliveira AG, Ueno M, Ara\u00fajo TG, Guadagnini D, Carvalho-Filho MA, et al. Modulation of double-stranded RNA-activated protein kinase in insulin sensitive tissues of obese humans. Obes (Silver Spring). 2013;21(12):2452\u20137.","journal-title":"Obes (Silver Spring)"},{"key":"1884_CR114","doi-asserted-by":"crossref","unstructured":"Shen J, Yang T, Xu Y, Luo Y, Zhong X, Shi L et al. \u03b4-Tocotrienol, isolated from rice bran, exerts an Anti-Inflammatory effect via MAPKs and PPARs signaling pathways in Lipopolysaccharide-Stimulated macrophages. Int J Mol Sci. 2018;19(10).","DOI":"10.3390\/ijms19103022"},{"issue":"7086","key":"1884_CR115","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1038\/nature04634","volume":"440","author":"N Houstis","year":"2006","unstructured":"Houstis N, Rosen ED, Lander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature. 2006;440(7086):944\u20138.","journal-title":"Nature"},{"issue":"12","key":"1884_CR116","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1038\/s41366-018-0075-4","volume":"42","author":"P Ormazabal","year":"2018","unstructured":"Ormazabal P, Scazzocchio B, Var\u00ec R, Santangelo C, D\u2019Archivio M, Silecchia G, et al. Effect of Protocatechuic acid on insulin responsiveness and inflammation in visceral adipose tissue from obese individuals: possible role for PTP1B. Int J Obes (Lond). 2018;42(12):2012\u201321.","journal-title":"Int J Obes (Lond)"},{"issue":"3","key":"1884_CR117","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1038\/nm.3084","volume":"19","author":"S Kiechl","year":"2013","unstructured":"Kiechl S, Wittmann J, Giaccari A, Knoflach M, Willeit P, Bozec A, et al. Blockade of receptor activator of nuclear factor-\u03baB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus. Nat Med. 2013;19(3):358\u201363.","journal-title":"Nat Med"},{"key":"1884_CR118","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1146\/annurev-immunol-031210-101322","volume":"29","author":"MF Gregor","year":"2011","unstructured":"Gregor MF, Hotamisligil GS. Inflammatory mechanisms in obesity. Annu Rev Immunol. 2011;29:415\u201345.","journal-title":"Annu Rev Immunol"},{"issue":"2","key":"1884_CR119","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/nm1706","volume":"14","author":"T Hosooka","year":"2008","unstructured":"Hosooka T, Noguchi T, Kotani K, Nakamura T, Sakaue H, Inoue H, et al. Dok1 mediates high-fat diet-induced adipocyte hypertrophy and obesity through modulation of PPAR-gamma phosphorylation. Nat Med. 2008;14(2):188\u201393.","journal-title":"Nat Med"},{"key":"1884_CR120","doi-asserted-by":"crossref","unstructured":"Boughanem H, Cabrera-Mulero A, Mill\u00e1n-G\u00f3mez M, Garrido-S\u00e1nchez L, Cardona F, Tinahones FJ et al. Transcriptional analysis of FOXO1, C\/EBP-\u03b1 and PPAR-\u03b32 genes and their association with Obesity-Related insulin resistance. Genes (Basel). 2019;10(9).","DOI":"10.3390\/genes10090706"},{"issue":"12","key":"1884_CR121","doi-asserted-by":"publisher","first-page":"22341","DOI":"10.3390\/molecules201219831","volume":"20","author":"PY Li","year":"2015","unstructured":"Li PY, Hsu CC, Yin MC, Kuo YH, Tang FY, Chao CY. Protective effects of red guava on inflammation and oxidative stress in Streptozotocin-Induced diabetic mice. Molecules. 2015;20(12):22341\u201350.","journal-title":"Molecules"},{"issue":"22","key":"1884_CR122","doi-asserted-by":"publisher","first-page":"5308","DOI":"10.1002\/anie.201107724","volume":"51","author":"T Esatbeyoglu","year":"2012","unstructured":"Esatbeyoglu T, Huebbe P, Ernst IM, Chin D, Wagner AE, Rimbach G. Curcumin\u2013from molecule to biological function. Angew Chem Int Ed Engl. 2012;51(22):5308\u201332.","journal-title":"Angew Chem Int Ed Engl"},{"issue":"6","key":"1884_CR123","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.biotechadv.2014.04.004","volume":"32","author":"S Prasad","year":"2014","unstructured":"Prasad S, Gupta SC, Tyagi AK, Aggarwal BB. Curcumin, a component of golden spice: from bedside to bench and back. Biotechnol Adv. 2014;32(6):1053\u201364.","journal-title":"Biotechnol Adv"},{"issue":"1\u20133","key":"1884_CR124","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0166-1280(02)00242-7","volume":"591","author":"JS Wright","year":"2002","unstructured":"Wright JS. Predicting the antioxidant activity of Curcumin and Curcuminoids. J Mol Struct (Thoechem). 2002;591(1\u20133):207\u201317.","journal-title":"J Mol Struct (Thoechem)"},{"issue":"1","key":"1884_CR125","doi-asserted-by":"publisher","first-page":"47","DOI":"10.2337\/db10-0867","volume":"60","author":"SE McQuaid","year":"2011","unstructured":"McQuaid SE, Hodson L, Neville MJ, Dennis AL, Cheeseman J, Humphreys SM, et al. Downregulation of adipose tissue fatty acid trafficking in obesity: a driver for ectopic fat deposition? Diabetes. 2011;60(1):47\u201355.","journal-title":"Diabetes"},{"issue":"1","key":"1884_CR126","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1124\/pr.110.004044","volume":"66","author":"M Heger","year":"2014","unstructured":"Heger M, van Golen RF, Broekgaarden M, Michel MC. The molecular basis for the pharmacokinetics and pharmacodynamics of Curcumin and its metabolites in relation to cancer. Pharmacol Rev. 2014;66(1):222\u2013307.","journal-title":"Pharmacol Rev"},{"issue":"4","key":"1884_CR127","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1080\/10408398.2018.1546669","volume":"60","author":"SV Luca","year":"2020","unstructured":"Luca SV, Macovei I, Bujor A, Miron A, Skalicka-Wo\u017aniak K, Aprotosoaie AC, et al. Bioactivity of dietary polyphenols: the role of metabolites. Crit Rev Food Sci Nutr. 2020;60(4):626\u201359.","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"3","key":"1884_CR128","first-page":"1058","volume":"61","author":"C Ireson","year":"2001","unstructured":"Ireson C, Orr S, Jones DJ, Verschoyle R, Lim C-K, Luo J-L, et al. Characterization of metabolites of the chemopreventive agent Curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production. Cancer Res. 2001;61(3):1058\u201364.","journal-title":"Cancer Res"},{"issue":"4","key":"1884_CR129","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/S0090-9556(24)15211-7","volume":"27","author":"M-H Pan","year":"1999","unstructured":"Pan M-H, Huang T-M, Lin J-K. Biotransformation of Curcumin through reduction and glucuronidation in mice. Drug Metab Dispos. 1999;27(4):486\u201394.","journal-title":"Drug Metab Dispos"},{"issue":"9","key":"1884_CR130","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1002\/mnfr.201200791","volume":"57","author":"MR Maradana","year":"2013","unstructured":"Maradana MR, Thomas R, O\u2019Sullivan BJ. Targeted delivery of Curcumin for treating type 2 diabetes. Mol Nutr Food Res. 2013;57(9):1550\u20136.","journal-title":"Mol Nutr Food Res"},{"issue":"5","key":"1884_CR131","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1007\/s10787-018-0466-0","volume":"26","author":"A Sadeghi","year":"2018","unstructured":"Sadeghi A, Rostamirad A, Seyyedebrahimi S, Meshkani R. Curcumin ameliorates palmitate-induced inflammation in skeletal muscle cells by regulating JNK\/NF-kB pathway and ROS production. Inflammopharmacology. 2018;26(5):1265\u201372.","journal-title":"Inflammopharmacology"},{"key":"1884_CR132","doi-asserted-by":"publisher","first-page":"369","DOI":"10.3389\/fphar.2016.00369","volume":"7","author":"F Kong","year":"2016","unstructured":"Kong F, Ye B, Cao J, Cai X, Lin L, Huang S, et al. Curcumin Represses NLRP3 Inflammasome Activation via TLR4\/MyD88\/NF-\u03baB and P2X7R Signaling in PMA-Induced Macrophages. Front Pharmacol. 2016;7:369.","journal-title":"Front Pharmacol"},{"issue":"04","key":"1884_CR133","first-page":"249","volume":"80","author":"N Pescosolido","year":"2014","unstructured":"Pescosolido N, Giannotti R, Plateroti AM, Pascarella A, Nebbioso M. Curcumin: therapeutical potential in ophthalmology. Planta Med. 2014;80(04):249\u201354.","journal-title":"Planta Med"},{"issue":"1","key":"1884_CR134","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s10787-016-0301-4","volume":"25","author":"Y Panahi","year":"2017","unstructured":"Panahi Y, Khalili N, Sahebi E, Namazi S, Karimian MS, Majeed M, et al. Antioxidant effects of curcuminoids in patients with type 2 diabetes mellitus: a randomized controlled trial. Inflammopharmacology. 2017;25(1):25\u201331.","journal-title":"Inflammopharmacology"},{"issue":"11","key":"1884_CR135","doi-asserted-by":"publisher","first-page":"4915","DOI":"10.3390\/app11114915","volume":"11","author":"A-M Matei","year":"2021","unstructured":"Matei A-M, Caruntu C, Tampa M, Georgescu SR, Matei C, Constantin MM, et al. Applications of nanosized-lipid-based drug delivery systems in wound care. Appl Sci. 2021;11(11):4915.","journal-title":"Appl Sci"},{"issue":"12","key":"1884_CR136","doi-asserted-by":"publisher","first-page":"4170","DOI":"10.1002\/jcb.26121","volume":"118","author":"J Hajavi","year":"2017","unstructured":"Hajavi J, Momtazi AA, Johnston TP, Banach M, Majeed M, Sahebkar A. Curcumin: a naturally occurring modulator of adipokines in diabetes. J Cell Biochem. 2017;118(12):4170\u201382.","journal-title":"J Cell Biochem"},{"key":"1884_CR137","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/978-0-387-46401-5_3","volume":"595","author":"VP Menon","year":"2007","unstructured":"Menon VP, Sudheer AR. Antioxidant and anti-inflammatory properties of Curcumin. Adv Exp Med Biol. 2007;595:105\u201325.","journal-title":"Adv Exp Med Biol"},{"issue":"6","key":"1884_CR138","doi-asserted-by":"publisher","first-page":"639","DOI":"10.2515\/therapie:2004110","volume":"59","author":"T Mahesh","year":"2004","unstructured":"Mahesh T, Balasubashini MMS, Menon VP. Photo-irradiated Curcumin supplementation in streptozotocin-induced diabetic rats: effect on lipid peroxidation. Therapies. 2004;59(6):639\u201344.","journal-title":"Therapies"},{"key":"1884_CR139","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.molimm.2019.09.020","volume":"116","author":"J Zhang","year":"2019","unstructured":"Zhang J, Zheng Y, Luo Y, Du Y, Zhang X, Fu J. Curcumin inhibits LPS-induced neuroinflammation by promoting microglial M2 polarization via TREM2\/ TLR4\/ NF-\u03baB pathways in BV2 cells. Mol Immunol. 2019;116:29\u201337.","journal-title":"Mol Immunol"},{"key":"1884_CR140","doi-asserted-by":"publisher","first-page":"669448","DOI":"10.3389\/fendo.2021.669448","volume":"12","author":"LT Marton","year":"2021","unstructured":"Marton LT, Pescinini ESLM, Camargo MEC, Barbalho SM, Haber J, Sinatora RV, et al. The effects of Curcumin on diabetes mellitus: A systematic review. Front Endocrinol (Lausanne). 2021;12:669448.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"1884_CR141","doi-asserted-by":"publisher","first-page":"841","DOI":"10.4161\/epi.21238","volume":"7","author":"ER Gilbert","year":"2012","unstructured":"Gilbert ER, Liu D. Epigenetics: the missing link to Understanding \u03b2-cell dysfunction in the pathogenesis of type 2 diabetes. Epigenetics. 2012;7(8):841\u201352.","journal-title":"Epigenetics"},{"key":"1884_CR142","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/alzrt179","volume":"5","author":"M Prior","year":"2013","unstructured":"Prior M, Dargusch R, Ehren JL, Chiruta C, Schubert D. The neurotrophic compound J147 reverses cognitive impairment in aged alzheimer\u2019s disease mice. Alzheimers Res Ther. 2013;5:1\u201319.","journal-title":"Alzheimers Res Ther"},{"key":"1884_CR143","doi-asserted-by":"crossref","unstructured":"Joshi RP, Negi G, Kumar A, Pawar YB, Munjal B, Bansal AK et al. SNEDDS curcumin formulation leads to enhanced protection from pain and functional deficits associated with diabetic neuropathy: an insight into its mechanism for neuroprotection. Nanomedicine: Nanotechnology, Biology and Medicine. 2013;9(6):776\u201385.","DOI":"10.1016\/j.nano.2013.01.001"},{"issue":"1","key":"1884_CR144","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1472-6882-6-10","volume":"6","author":"CD Lao","year":"2006","unstructured":"Lao CD, Ruffin MT, Normolle D, Heath DD, Murray SI, Bailey JM, et al. Dose escalation of a curcuminoid formulation. BMC Complement Altern Med. 2006;6(1):10.","journal-title":"BMC Complement Altern Med"},{"key":"1884_CR145","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.cbi.2015.06.025","volume":"238","author":"N Greeshma","year":"2015","unstructured":"Greeshma N, Prasanth K, Balaji B. Tetrahydrocurcumin exerts protective effect on vincristine induced neuropathy: behavioral, biochemical, neurophysiological and histological evidence. Chemico-Biol Interact. 2015;238:118\u201328.","journal-title":"Chemico-Biol Interact"},{"issue":"1","key":"1884_CR146","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neulet.2012.01.019","volume":"511","author":"AD Kandhare","year":"2012","unstructured":"Kandhare AD, Raygude KS, Ghosh P, Ghule AE, Bodhankar SL. Therapeutic role of Curcumin in prevention of biochemical and behavioral aberration induced by alcoholic neuropathy in laboratory animals. Neurosci Lett. 2012;511(1):18\u201322.","journal-title":"Neurosci Lett"},{"key":"1884_CR147","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.neulet.2013.12.019","volume":"560","author":"W-C Zhao","year":"2014","unstructured":"Zhao W-C, Zhang B, Liao M-J, Zhang W-X, He W-Y, Wang H-B, et al. Curcumin ameliorated diabetic neuropathy partially by Inhibition of NADPH oxidase mediating oxidative stress in the spinal cord. Neurosci Lett. 2014;560:81\u20135.","journal-title":"Neurosci Lett"},{"issue":"3","key":"1884_CR148","first-page":"e20200447","volume":"95","author":"RS Silveira","year":"2023","unstructured":"Silveira RS, Baldoni AO, Couto RO, Mendonca TS, Domingueti CP. In vivo efficacy of turmeric (Curcuma longa L.) in the treatment of peripheral neuropathy: A systematic review of animal models. An Acad Bras Cienc. 2023;95(3):e20200447.","journal-title":"An Acad Bras Cienc"},{"key":"1884_CR149","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.ejphar.2017.12.008","volume":"819","author":"T Akaishi","year":"2018","unstructured":"Akaishi T, Abe K. CNB-001, a synthetic pyrazole derivative of curcumin, suppresses lipopolysaccharide-induced nitric oxide production through the Inhibition of NF-\u03baB and p38 MAPK pathways in microglia. Eur J Pharmacol. 2018;819:190\u20137.","journal-title":"Eur J Pharmacol"},{"issue":"12","key":"1884_CR150","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1038\/nrg3074","volume":"12","author":"M Esteller","year":"2011","unstructured":"Esteller M. Non-coding RNAs in human disease. Nat Rev Genet. 2011;12(12):861\u201374.","journal-title":"Nat Rev Genet"},{"issue":"7","key":"1884_CR151","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1016\/j.pain.2011.01.042","volume":"152","author":"E Niederberger","year":"2011","unstructured":"Niederberger E, Kynast K, L\u00f6tsch J, Geisslinger G. MicroRNAs as new players in the pain game. Pain. 2011;152(7):1455\u20138.","journal-title":"Pain"},{"issue":"2","key":"1884_CR152","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281\u201397.","journal-title":"Cell"},{"issue":"10","key":"1884_CR153","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/cr.2008.282","volume":"18","author":"X Chen","year":"2008","unstructured":"Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, et al. Characterization of MicroRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008;18(10):997\u20131006.","journal-title":"Cell Res"},{"issue":"9","key":"1884_CR154","doi-asserted-by":"publisher","first-page":"1974","DOI":"10.3390\/ijms18091974","volume":"18","author":"V La Marca","year":"2017","unstructured":"La Marca V, Fierabracci A. Insights into the diagnostic potential of extracellular vesicles and their MiRNA signature from liquid biopsy as early biomarkers of diabetic micro\/macrovascular complications. Int J Mol Sci. 2017;18(9):1974.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"1884_CR155","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1042\/CS20130079","volume":"126","author":"AD McClelland","year":"2014","unstructured":"McClelland AD, Kantharidis P. MicroRNA in the development of diabetic complications. Clin Sci. 2014;126(2):95\u2013110.","journal-title":"Clin Sci"},{"issue":"4","key":"1884_CR156","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1111\/j.1474-9726.2012.00824.x","volume":"11","author":"A ElSharawy","year":"2012","unstructured":"ElSharawy A, Keller A, Flachsbart F, Wendschlag A, Jacobs G, Kefer N, et al. Genome-wide MiRNA signatures of human longevity. Aging Cell. 2012;11(4):607\u201316.","journal-title":"Aging Cell"},{"issue":"1","key":"1884_CR157","doi-asserted-by":"publisher","first-page":"10201","DOI":"10.1038\/srep10201","volume":"5","author":"J Wang","year":"2015","unstructured":"Wang J, Tan L, Tan L, Tian Y, Ma J, Tan C-C, et al. Circulating MicroRNAs are promising novel biomarkers for drug-resistant epilepsy. Sci Rep. 2015;5(1):10201.","journal-title":"Sci Rep"},{"issue":"1","key":"1884_CR158","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/ijo.2015.170","volume":"40","author":"JA Deiuliis","year":"2016","unstructured":"Deiuliis JA. MicroRNAs as regulators of metabolic disease: pathophysiologic significance and emerging role as biomarkers and therapeutics. Int J Obes (Lond). 2016;40(1):88\u2013101.","journal-title":"Int J Obes (Lond)"},{"issue":"2","key":"1884_CR159","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1042\/CS20130079","volume":"126","author":"AD McClelland","year":"2014","unstructured":"McClelland AD, Kantharidis P. MicroRNA in the development of diabetic complications. Clin Sci (Lond). 2014;126(2):95\u2013110.","journal-title":"Clin Sci (Lond)"},{"issue":"11","key":"1884_CR160","doi-asserted-by":"publisher","first-page":"3663","DOI":"10.2337\/dc13-0382","volume":"36","author":"C Herder","year":"2013","unstructured":"Herder C, Bongaerts BW, Rathmann W, Heier M, Kowall B, Koenig W, et al. Association of subclinical inflammation with polyneuropathy in the older population: KORA F4 study. Diabetes Care. 2013;36(11):3663\u201370.","journal-title":"Diabetes Care"},{"issue":"7","key":"1884_CR161","doi-asserted-by":"publisher","first-page":"4402","DOI":"10.1167\/iovs.10-6879","volume":"52","author":"B Kovacs","year":"2011","unstructured":"Kovacs B, Lumayag S, Cowan C, Xu S. MicroRNAs in early diabetic retinopathy in streptozotocin-induced diabetic rats. Investig Ophthalmol Vis Sci. 2011;52(7):4402\u20139.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"1884_CR162","unstructured":"Wilson N, Wright D. Inflammatory mediators in diabetic neuropathy. J Diabetes Metab. 2011;5(004)."},{"issue":"12","key":"1884_CR163","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1038\/nrn2037","volume":"7","author":"KS Kosik","year":"2006","unstructured":"Kosik KS. The neuronal MicroRNA system. Nat Rev Neurosci. 2006;7(12):911\u201320.","journal-title":"Nat Rev Neurosci"},{"issue":"17","key":"1884_CR164","doi-asserted-by":"publisher","first-page":"4322","DOI":"10.1523\/JNEUROSCI.4815-07.2008","volume":"28","author":"TH Davis","year":"2008","unstructured":"Davis TH, Cuellar TL, Koch SM, Barker AJ, Harfe BD, McManus MT, et al. Conditional loss of Dicer disrupts cellular and tissue morphogenesis in the cortex and hippocampus. J Neurosci. 2008;28(17):4322\u201330.","journal-title":"J Neurosci"},{"issue":"4","key":"1884_CR165","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.tins.2008.12.003","volume":"32","author":"SS H\u00e9bert","year":"2009","unstructured":"H\u00e9bert SS, De Strooper B. Alterations of the MicroRNA network cause neurodegenerative disease. Trends Neurosci. 2009;32(4):199\u2013206.","journal-title":"Trends Neurosci"},{"key":"1884_CR166","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s12017-009-8065-2","volume":"11","author":"NR Smalheiser","year":"2009","unstructured":"Smalheiser NR, Lugli G. MicroRNA regulation of synaptic plasticity. Neuromol Med. 2009;11:133\u201340.","journal-title":"Neuromol Med"},{"issue":"10","key":"1884_CR167","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.2174\/13894501113149990182","volume":"14","author":"C Chakraborty","year":"2013","unstructured":"Chakraborty C, Priya D, Bandyopadhyay S. MiRNAs in insulin resistance and diabetes-associated pancreatic cancer: the \u2018minute and miracle\u2019molecule moving as a monitor in the \u2018genomic galaxy\u2019. Curr Drug Targets. 2013;14(10):1110\u20137.","journal-title":"Curr Drug Targets"},{"issue":"2","key":"1884_CR168","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.bbrc.2013.04.089","volume":"435","author":"A Sakai","year":"2013","unstructured":"Sakai A, Suzuki H. Nerve injury-induced upregulation of miR-21 in the primary sensory neurons contributes to neuropathic pain in rats. Biochem Biophys Res Commun. 2013;435(2):176\u201381.","journal-title":"Biochem Biophys Res Commun"},{"issue":"17","key":"1884_CR169","doi-asserted-by":"publisher","first-page":"5369","DOI":"10.1128\/MCB.00479-08","volume":"28","author":"G Gabriely","year":"2008","unstructured":"Gabriely G, Wurdinger T, Kesari S, Esau CC, Burchard J, Linsley PS, et al. MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol Cell Biol. 2008;28(17):5369\u201380.","journal-title":"Mol Cell Biol"},{"issue":"1","key":"1884_CR170","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/1756-9966-29-29","volume":"29","author":"B Song","year":"2010","unstructured":"Song B, Wang C, Liu J, Wang X, Lv L, Wei L, et al. MicroRNA-21 regulates breast cancer invasion partly by targeting tissue inhibitor of metalloproteinase 3 expression. J Exp Clin Cancer Res. 2010;29(1):29.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"1884_CR171","first-page":"195","volume":"24","author":"X Zhou","year":"2010","unstructured":"Zhou X, Zhang J, Jia Q, Ren Y, Wang Y, Shi L, et al. Reduction of miR-21 induces glioma cell apoptosis via activating caspase 9 and 3. Oncol Rep. 2010;24(1):195\u2013201.","journal-title":"Oncol Rep"},{"issue":"3","key":"1884_CR172","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/nm1723","volume":"14","author":"Y Kawasaki","year":"2008","unstructured":"Kawasaki Y, Xu ZZ, Wang X, Park JY, Zhuang ZY, Tan PH, et al. Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain. Nat Med. 2008;14(3):331\u20136.","journal-title":"Nat Med"},{"issue":"8","key":"1884_CR173","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1091\/mbc.e08-02-0159","volume":"19","author":"D Sayed","year":"2008","unstructured":"Sayed D, Rane S, Lypowy J, He M, Chen IY, Vashistha H, et al. MicroRNA-21 targets Sprouty2 and promotes cellular outgrowths. Mol Biol Cell. 2008;19(8):3272\u201382.","journal-title":"Mol Biol Cell"},{"issue":"3","key":"1884_CR174","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ccr.2010.08.013","volume":"18","author":"ME Hatley","year":"2010","unstructured":"Hatley ME, Patrick DM, Garcia MR, Richardson JA, Bassel-Duby R, van Rooij E, et al. Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. Cancer Cell. 2010;18(3):282\u201393.","journal-title":"Cancer Cell"},{"issue":"7","key":"1884_CR175","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/cr.2009.72","volume":"19","author":"M Liu","year":"2009","unstructured":"Liu M, Wu H, Liu T, Li Y, Wang F, Wan H, et al. Regulation of the cell cycle gene, BTG2, by miR-21 in human laryngeal carcinoma. Cell Res. 2009;19(7):828\u201337.","journal-title":"Cell Res"},{"issue":"6","key":"1884_CR176","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.1002\/jcb.24479","volume":"114","author":"Y Mei","year":"2013","unstructured":"Mei Y, Bian C, Li J, Du Z, Zhou H, Yang Z, et al. miR-21 modulates the ERK-MAPK signaling pathway by regulating SPRY2 expression during human mesenchymal stem cell differentiation. J Cell Biochem. 2013;114(6):1374\u201384.","journal-title":"J Cell Biochem"},{"issue":"45","key":"1884_CR177","doi-asserted-by":"publisher","first-page":"10211","DOI":"10.1523\/JNEUROSCI.3388-04.2004","volume":"24","author":"K Obata","year":"2004","unstructured":"Obata K, Yamanaka H, Kobayashi K, Dai Y, Mizushima T, Katsura H, et al. Role of mitogen-activated protein kinase activation in injured and intact primary afferent neurons for mechanical and heat hypersensitivity after spinal nerve ligation. J Neurosci. 2004;24(45):10211\u201322.","journal-title":"J Neurosci"},{"key":"1884_CR178","doi-asserted-by":"crossref","unstructured":"Ruan Q, Wang T, Kameswaran V, Wei Q, Johnson DS, Matschinsky F et al. The microRNA-21\u2013\u2009PDCD4 axis prevents type 1 diabetes by blocking pancreatic \u03b2 cell death. Proceedings of the National Academy of Sciences. 2011;108(29):12030-5.","DOI":"10.1073\/pnas.1101450108"},{"issue":"2","key":"1884_CR179","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1053\/j.gastro.2007.05.022","volume":"133","author":"F Meng","year":"2007","unstructured":"Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology. 2007;133(2):647\u201358.","journal-title":"Gastroenterology"},{"issue":"9","key":"1884_CR180","doi-asserted-by":"publisher","first-page":"e44768","DOI":"10.1371\/journal.pone.0044768","volume":"7","author":"S Zhou","year":"2012","unstructured":"Zhou S, Shen D, Wang Y, Gong L, Tang X, Yu B, et al. microRNA-222 targeting PTEN promotes neurite outgrowth from adult dorsal root ganglion neurons following sciatic nerve transection. PLoS ONE. 2012;7(9):e44768.","journal-title":"PLoS ONE"},{"issue":"2","key":"1884_CR181","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.expneurol.2007.05.029","volume":"206","author":"JT Xu","year":"2007","unstructured":"Xu JT, Tu HY, Xin WJ, Liu XG, Zhang GH, Zhai CH. Activation of phosphatidylinositol 3-kinase and protein kinase b\/akt in dorsal root ganglia and spinal cord contributes to the neuropathic pain induced by spinal nerve ligation in rats. Exp Neurol. 2007;206(2):269\u201379.","journal-title":"Exp Neurol"},{"issue":"1","key":"1884_CR182","doi-asserted-by":"publisher","first-page":"3545","DOI":"10.1038\/s41467-022-31317-0","volume":"13","author":"R Liu","year":"2022","unstructured":"Liu R, Liu C, He X, Sun P, Zhang B, Yang H, et al. MicroRNA-21 promotes pancreatic \u03b2 cell function through modulating glucose uptake. Nat Commun. 2022;13(1):3545.","journal-title":"Nat Commun"},{"issue":"20","key":"1884_CR183","doi-asserted-by":"publisher","first-page":"7269","DOI":"10.1073\/pnas.0802682105","volume":"105","author":"K Jazdzewski","year":"2008","unstructured":"Jazdzewski K, Murray EL, Franssila K, Jarzab B, Schoenberg DR, de la Chapelle A. Common SNP in pre-miR-146a decreases mature MiR expression and predisposes to papillary thyroid carcinoma. Proc Natl Acad Sci U S A. 2008;105(20):7269\u201374.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"1884_CR184","first-page":"156","volume":"6","author":"B Alipoor","year":"2017","unstructured":"Alipoor B, Ghaedi H, Meshkani R, Torkamandi S, Saffari S, Iranpour M, et al. Association of MiR-146a expression and type 2 diabetes mellitus: A Meta-Analysis. Int J Mol Cell Med. 2017;6(3):156\u201363.","journal-title":"Int J Mol Cell Med"},{"issue":"11","key":"1884_CR185","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1210\/me.2007-0167","volume":"21","author":"A He","year":"2007","unstructured":"He A, Zhu L, Gupta N, Chang Y, Fang F. Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes. Mol Endocrinol. 2007;21(11):2785\u201394.","journal-title":"Mol Endocrinol"},{"issue":"33","key":"1884_CR186","doi-asserted-by":"publisher","first-page":"12481","DOI":"10.1073\/pnas.0605298103","volume":"103","author":"KD Taganov","year":"2006","unstructured":"Taganov KD, Boldin MP, Chang KJ, Baltimore D. NF-kappaB-dependent induction of MicroRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci U S A. 2006;103(33):12481\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1884_CR187","doi-asserted-by":"publisher","first-page":"293","DOI":"10.3389\/fimmu.2018.00293","volume":"9","author":"H Wang","year":"2018","unstructured":"Wang H, Zhang Y, Wu X, Wang Y, Cui H, Li X, et al. Regulation of human natural killer cell IFN-\u03b3 production by MicroRNA-146a via targeting the NF-\u03baB signaling pathway. Front Immunol. 2018;9:293.","journal-title":"Front Immunol"},{"key":"1884_CR188","doi-asserted-by":"crossref","unstructured":"Feng Y, Chen L, Luo Q, Wu M, Chen Y, Shi X. Involvement of microRNA-146a in diabetic peripheral neuropathy through the regulation of inflammation. Drug Design, Development and Therapy. 2018:171-7.","DOI":"10.2147\/DDDT.S157109"},{"issue":"12","key":"1884_CR189","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.2337\/db16-1182","volume":"66","author":"XS Liu","year":"2017","unstructured":"Liu XS, Fan B, Szalad A, Jia L, Wang L, Wang X, et al. MicroRNA-146a mimics reduce the peripheral neuropathy in type 2 diabetic mice. Diabetes. 2017;66(12):3111\u201321.","journal-title":"Diabetes"},{"key":"1884_CR190","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2147\/DDDT.S157109","volume":"12","author":"Y Feng","year":"2018","unstructured":"Feng Y, Chen L, Luo Q, Wu M, Chen Y, Shi X. Involvement of microRNA-146a in diabetic peripheral neuropathy through the regulation of inflammation. Drug Des Devel Ther. 2018;12:171\u20137.","journal-title":"Drug Des Devel Ther"},{"key":"1884_CR191","doi-asserted-by":"publisher","first-page":"113694","DOI":"10.1016\/j.expneurol.2021.113694","volume":"341","author":"B Fan","year":"2021","unstructured":"Fan B, Chopp M, Zhang ZG, Liu XS. Treatment of diabetic peripheral neuropathy with engineered mesenchymal stromal cell-derived exosomes enriched with microRNA-146a provide amplified therapeutic efficacy. Exp Neurol. 2021;341:113694.","journal-title":"Exp Neurol"},{"issue":"9","key":"1884_CR192","doi-asserted-by":"publisher","first-page":"e0204252","DOI":"10.1371\/journal.pone.0204252","volume":"13","author":"K Kubota","year":"2018","unstructured":"Kubota K, Nakano M, Kobayashi E, Mizue Y, Chikenji T, Otani M, et al. An enriched environment prevents diabetes-induced cognitive impairment in rats by enhancing Exosomal miR-146a secretion from endogenous bone marrow-derived mesenchymal stem cells. PLoS ONE. 2018;13(9):e0204252.","journal-title":"PLoS ONE"},{"key":"1884_CR193","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1475-2867-13-50","volume":"13","author":"M Sha","year":"2013","unstructured":"Sha M, Ye J, Zhang L-x, Luan Z-y, Chen Y-b. Celastrol induces apoptosis of gastric cancer cells by miR-146a Inhibition of NF-\u03baB activity. Cancer Cell Int. 2013;13:1\u20138.","journal-title":"Cancer Cell Int"},{"issue":"7","key":"1884_CR194","doi-asserted-by":"publisher","first-page":"575","DOI":"10.2217\/epi-2019-0242","volume":"12","author":"C Ciccacci","year":"2020","unstructured":"Ciccacci C, Latini A, Colantuono A, Politi C, D\u2019Amato C, Greco C, et al. Expression study of candidate MiRNAs and evaluation of their potential use as biomarkers of diabetic neuropathy. Epigenomics. 2020;12(7):575\u201385.","journal-title":"Epigenomics"},{"issue":"3","key":"1884_CR195","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.clnu.2019.03.033","volume":"39","author":"NH Kim","year":"2020","unstructured":"Kim NH, Ahn J, Choi YM, Son HJ, Choi WH, Cho HJ, et al. Differential Circulating and visceral fat MicroRNA expression of non-obese and obese subjects. Clin Nutr. 2020;39(3):910\u20136.","journal-title":"Clin Nutr"},{"issue":"3","key":"1884_CR196","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.arcmed.2019.07.002","volume":"50","author":"M Mostahfezian","year":"2019","unstructured":"Mostahfezian M, Azhir Z, Dehghanian F, Hojati Z. Expression pattern of micrornas, miR-21, miR-155 and miR-338 in patients with type 1 diabetes. Arch Med Res. 2019;50(3):79\u201385.","journal-title":"Arch Med Res"},{"key":"1884_CR197","doi-asserted-by":"crossref","unstructured":"Jankauskas SS, Gambardella J, Sardu C, Lombardi A, Santulli G. Functional role of miR-155 in the pathogenesis of diabetes mellitus and its complications. Noncoding RNA. 2021;7(3).","DOI":"10.3390\/ncrna7030039"},{"issue":"31","key":"1884_CR198","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.1038\/onc.2011.538","volume":"31","author":"J Lu","year":"2012","unstructured":"Lu J, Hamze Z, Bonnavion R, Herath N, Pouponnot C, Assade F, et al. Reexpression of oncoprotein MafB in proliferative \u03b2-cells and Men1 insulinomas in mouse. Oncogene. 2012;31(31):3647\u201354.","journal-title":"Oncogene"},{"issue":"2","key":"1884_CR199","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.cmet.2018.09.011","volume":"29","author":"C Guay","year":"2019","unstructured":"Guay C, Kruit JK, Rome S, Menoud V, Mulder NL, Jurdzinski A, et al. Lymphocyte-derived Exosomal MicroRNAs promote pancreatic \u03b2 cell death and May contribute to type 1 diabetes development. Cell Metabol. 2019;29(2):348\u201361. e6.","journal-title":"Cell Metabol"},{"issue":"1","key":"1884_CR200","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.cellimm.2012.11.001","volume":"280","author":"S Shao","year":"2012","unstructured":"Shao S, He F, Yang Y, Yuan G, Zhang M, Yu X. Th17 cells in type 1 diabetes. Cell Immunol. 2012;280(1):16\u201321.","journal-title":"Cell Immunol"},{"issue":"2","key":"1884_CR201","first-page":"429","volume":"45","author":"A Chen","year":"2020","unstructured":"Chen A, Wen J, Lu C, Lin B, Xian S, Huang F, et al. Inhibition of miR\u2013155\u20135p attenuates the valvular damage induced by rheumatic heart disease. Int J Mol Med. 2020;45(2):429\u201340.","journal-title":"Int J Mol Med"},{"issue":"15","key":"1884_CR202","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1038\/sj.onc.1210856","volume":"27","author":"IA Asangani","year":"2008","unstructured":"Asangani IA, Rasheed SA, Nikolova D, Leupold J, Colburn N, Post S, et al. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene. 2008;27(15):2128\u201336.","journal-title":"Oncogene"},{"issue":"4","key":"1884_CR203","doi-asserted-by":"publisher","first-page":"5461","DOI":"10.3892\/mmr.2015.4087","volume":"12","author":"H Wu","year":"2015","unstructured":"Wu H, Liu Q, Cai T, Chen YD, Wang ZF. Induction of microRNA-146a is involved in curcumin-mediated enhancement of Temozolomide cytotoxicity against human glioblastoma. Mol Med Rep. 2015;12(4):5461\u20136.","journal-title":"Mol Med Rep"},{"issue":"2","key":"1884_CR204","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.bcp.2014.02.026","volume":"89","author":"L Wang","year":"2014","unstructured":"Wang L, Xu Y, Yu Q, Sun Q, Xu Y, Gu Q, et al. H-RN, a novel antiangiogenic peptide derived from hepatocyte growth factor inhibits inflammation in vitro and in vivo through PI3K\/AKT\/IKK\/NF-\u03baB signal pathway. Biochem Pharmacol. 2014;89(2):255\u201365.","journal-title":"Biochem Pharmacol"},{"issue":"42","key":"1884_CR205","doi-asserted-by":"publisher","first-page":"17408","DOI":"10.1073\/pnas.1112660108","volume":"108","author":"MV Rajaram","year":"2011","unstructured":"Rajaram MV, Ni B, Morris JD, Brooks MN, Carlson TK, Bakthavachalu B, et al. Mycobacterium tuberculosis Lipomannan blocks TNF biosynthesis by regulating macrophage MAPK-activated protein kinase 2 (MK2) and MicroRNA miR-125b. Proc Natl Acad Sci. 2011;108(42):17408\u201313.","journal-title":"Proc Natl Acad Sci"},{"issue":"10","key":"1884_CR206","doi-asserted-by":"publisher","first-page":"950","DOI":"10.3390\/antiox9100950","volume":"9","author":"M Caillaud","year":"2020","unstructured":"Caillaud M, Aung Myo YP, McKiver BD, Osinska Warncke U, Thompson D, Mann J, et al. Key developments in the potential of Curcumin for the treatment of peripheral neuropathies. Antioxidants. 2020;9(10):950.","journal-title":"Antioxidants"},{"key":"1884_CR207","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1007\/s11684-019-0729-1","volume":"14","author":"P Zhang","year":"2020","unstructured":"Zhang P, Li T, Wu X, Nice EC, Huang C, Zhang Y. Oxidative stress and diabetes: antioxidative strategies. Front Med. 2020;14:583\u2013600.","journal-title":"Front Med"},{"issue":"5","key":"1884_CR208","doi-asserted-by":"publisher","first-page":"491","DOI":"10.4103\/1735-1995.163977","volume":"20","author":"H Nasri","year":"2015","unstructured":"Nasri H, Shirzad H, Baradaran A, Rafieian-Kopaei M. Antioxidant plants and diabetes mellitus. J Res Med Sci. 2015;20(5):491\u2013502.","journal-title":"J Res Med Sci"},{"key":"1884_CR209","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.redox.2016.12.022","volume":"11","author":"L Xiao","year":"2017","unstructured":"Xiao L, Xu X, Zhang F, Wang M, Xu Y, Tang D, et al. The mitochondria-targeted antioxidant MitoQ ameliorated tubular injury mediated by mitophagy in diabetic kidney disease via Nrf2\/PINK1. Redox Biol. 2017;11:297\u2013311.","journal-title":"Redox Biol"},{"issue":"1","key":"1884_CR210","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1053\/j.jrn.2011.03.002","volume":"22","author":"P Khajehdehi","year":"2012","unstructured":"Khajehdehi P, Zanjaninejad B, Aflaki E, Nazarinia M, Azad F, Malekmakan L, et al. Oral supplementation of turmeric decreases proteinuria, hematuria, and systolic blood pressure in patients suffering from relapsing or refractory lupus nephritis: a randomized and placebo-controlled study. J Ren Nutr. 2012;22(1):50\u20137.","journal-title":"J Ren Nutr"},{"key":"1884_CR211","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.ejmech.2018.12.016","volume":"163","author":"B Salehi","year":"2019","unstructured":"Salehi B, Stojanovi\u0107-Radi\u0107 Z, Mateji\u0107 J, Sharifi-Rad M, Kumar NVA, Martins N, et al. The therapeutic potential of curcumin: A review of clinical trials. Eur J Med Chem. 2019;163:527\u201345.","journal-title":"Eur J Med Chem"},{"key":"1884_CR212","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.ejphar.2013.11.033","volume":"723","author":"HR Banafshe","year":"2014","unstructured":"Banafshe HR, Hamidi GA, Noureddini M, Mirhashemi SM, Mokhtari R, Shoferpour M. Effect of Curcumin on diabetic peripheral neuropathic pain: possible involvement of opioid system. Eur J Pharmacol. 2014;723:202\u20136.","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"1884_CR213","doi-asserted-by":"publisher","first-page":"332","DOI":"10.2174\/138945011794815356","volume":"12","author":"H Zhou","year":"2011","unstructured":"Zhou H, Beevers S, Huang C. The targets of Curcumin. Curr Drug Targets. 2011;12(3):332\u201347.","journal-title":"Curr Drug Targets"},{"issue":"1","key":"1884_CR214","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jtcms.2020.01.001","volume":"7","author":"L Zhang","year":"2020","unstructured":"Zhang L, Liu Y, Wang X, Li C, Shen M, Di L, et al. Curcumin alleviates TGF-\u03b21-induced fibrosis in NRK-49F cells via suppression of miR-21 expression, and regulation of the TGF-\u03b21\/smad3 signaling pathway. J Traditional Chin Med Sci. 2020;7(1):68\u201374.","journal-title":"J Traditional Chin Med Sci"},{"key":"1884_CR215","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.ctim.2019.02.014","volume":"43","author":"S Asadi","year":"2019","unstructured":"Asadi S, Gholami MS, Siassi F, Qorbani M, Khamoshian K, Sotoudeh G. Nano Curcumin supplementation reduced the severity of diabetic sensorimotor polyneuropathy in patients with type 2 diabetes mellitus: A randomized double-blind placebo-controlled clinical trial. Complement Ther Med. 2019;43:253\u201360.","journal-title":"Complement Ther Med"},{"issue":"9","key":"1884_CR216","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1002\/mnfr.201200131","volume":"57","author":"LX Na","year":"2013","unstructured":"Na LX, Li Y, Pan HZ, Zhou XL, Sun DJ, Meng M, et al. Curcuminoids exert glucose-lowering effect in type 2 diabetes by decreasing serum free fatty acids: A double\u2010blind, placebo\u2010controlled trial. Mol Nutr Food Res. 2013;57(9):1569\u201377.","journal-title":"Mol Nutr Food Res"},{"issue":"5","key":"1884_CR217","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.ctim.2014.07.006","volume":"22","author":"Y Panahi","year":"2014","unstructured":"Panahi Y, Khalili N, Hosseini MS, Abbasinazari M, Sahebkar A. Lipid-modifying effects of adjunctive therapy with curcuminoids\u2013piperine combination in patients with metabolic syndrome: results of a randomized controlled trial. Complement Ther Med. 2014;22(5):851\u20137.","journal-title":"Complement Ther Med"},{"issue":"9","key":"1884_CR218","doi-asserted-by":"publisher","first-page":"4666","DOI":"10.3390\/ijms22094666","volume":"22","author":"P Basu","year":"2021","unstructured":"Basu P, Maier C, Basu A. Effects of Curcumin and its different formulations in preclinical and clinical studies of peripheral neuropathic and postoperative pain: A comprehensive review. Int J Mol Sci. 2021;22(9):4666.","journal-title":"Int J Mol Sci"},{"issue":"12","key":"1884_CR219","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1002\/ptr.5201","volume":"28","author":"P Neerati","year":"2014","unstructured":"Neerati P, Devde R, Gangi AK. Evaluation of the effect of Curcumin capsules on glyburide therapy in patients with type-2 diabetes mellitus. Phytother Res. 2014;28(12):1796\u2013800.","journal-title":"Phytother Res"},{"issue":"1\u20132","key":"1884_CR220","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/0378-8741(91)90167-C","volume":"33","author":"R Kulkarni","year":"1991","unstructured":"Kulkarni R, Patki P, Jog V, Gandage S, Patwardhan B. Treatment of osteoarthritis with a herbomineral formulation: a double-blind, placebo-controlled, cross-over study. J Ethnopharmacol. 1991;33(1\u20132):91\u20135.","journal-title":"J Ethnopharmacol"},{"issue":"8","key":"1884_CR221","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1089\/acm.2008.0186","volume":"15","author":"V Kuptniratsaikul","year":"2009","unstructured":"Kuptniratsaikul V, Thanakhumtorn S, Chinswangwatanakul P, Wattanamongkonsil L, Thamlikitkul V. Efficacy and safety of curcuma domestica extracts in patients with knee osteoarthritis. J Altern Complement Med. 2009;15(8):891\u20137.","journal-title":"J Altern Complement Med"},{"issue":"Suppl 1","key":"1884_CR222","first-page":"S51","volume":"95","author":"P Pinsornsak","year":"2012","unstructured":"Pinsornsak P, Niempoog S. The efficacy of curcuma longa L. extract as an adjuvant therapy in primary knee osteoarthritis: a randomized control trial. J Med Assoc Thai. 2012;95(Suppl 1):S51\u20138.","journal-title":"J Med Assoc Thai"},{"key":"1884_CR223","doi-asserted-by":"crossref","unstructured":"Kuptniratsaikul V, Dajpratham P, Taechaarpornkul W, Buntragulpoontawee M, Lukkanapichonchut P, Chootip C et al. Efficacy and safety of curcuma domestica extracts compared with ibuprofen in patients with knee osteoarthritis: a multicenter study. Clin Interv Aging. 2014:451\u20138.","DOI":"10.2147\/CIA.S58535"},{"issue":"2","key":"1884_CR224","first-page":"105","volume":"44","author":"N Kertia","year":"2012","unstructured":"Kertia N, Asdie AH, Rochmah W. Ability of curcuminoid compared to diclofenac sodium in reducing the secretion of cycloxygenase-2 enzyme by synovial fluid\u2019s monocytes of patients with osteoarthritis. Acta Med Indones. 2012;44(2):105\u201313.","journal-title":"Acta Med Indones"},{"issue":"11","key":"1884_CR225","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1002\/ptr.5174","volume":"28","author":"Y Panahi","year":"2014","unstructured":"Panahi Y, Rahimnia AR, Sharafi M, Alishiri G, Saburi A, Sahebkar A. Curcuminoid treatment for knee osteoarthritis: A randomized double-blind placebo\u2010controlled trial. Phytother Res. 2014;28(11):1625\u201331.","journal-title":"Phytother Res"},{"issue":"12","key":"1884_CR226","first-page":"651","volume":"24","author":"R Satoskar","year":"1986","unstructured":"Satoskar R, Shah S, Shenoy S. Evaluation of anti-inflammatory property of Curcumin (diferuloyl methane) in patients with postoperative inflammation. Int J Clin Pharmacol Therapy Toxicol. 1986;24(12):651\u20134.","journal-title":"Int J Clin Pharmacol Therapy Toxicol"},{"key":"1884_CR227","doi-asserted-by":"publisher","first-page":"243","DOI":"10.2165\/00126839-200809040-00004","volume":"9","author":"P Usharani","year":"2008","unstructured":"Usharani P, Mateen A, Naidu M, Raju Y, Chandra N. Effect of NCB-02, Atorvastatin and placebo on endothelial function, oxidative stress and inflammatory markers in patients with type 2 diabetes mellitus: a randomized, parallel-group, placebo-controlled, 8-week study. Drugs R D. 2008;9:243\u201350.","journal-title":"Drugs R D"},{"issue":"12","key":"1884_CR228","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1002\/ptr.4952","volume":"27","author":"A Sahebkar","year":"2013","unstructured":"Sahebkar A, Mohammadi A, Atabati A, Rahiman S, Tavallaie S, Iranshahi M, et al. Curcuminoids modulate pro-oxidant\u2013antioxidant balance but not the immune response to heat shock protein 27 and oxidized LDL in obese individuals. Phytother Res. 2013;27(12):1883\u20138.","journal-title":"Phytother Res"},{"issue":"4","key":"1884_CR229","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s11130-012-0325-x","volume":"67","author":"DC Nieman","year":"2012","unstructured":"Nieman DC, Cialdella-Kam L, Knab AM, Shanely RA. Influence of red pepper spice and turmeric on inflammation and oxidative stress biomarkers in overweight females: a metabolomics approach. Plant Foods Hum Nutr. 2012;67(4):415\u201321.","journal-title":"Plant Foods Hum Nutr"},{"issue":"21","key":"1884_CR230","first-page":"4195","volume":"19","author":"F Di Pierro","year":"2015","unstructured":"Di Pierro F, Bressan A, Ranaldi D, Rapacioli G, Giacomelli L, Bertuccioli A. Potential role of bioavailable Curcumin in weight loss and omental adipose tissue decrease: preliminary data of a randomized, controlled trial in overweight people with metabolic syndrome. Preliminary study. Eur Rev Med Pharmacol Sci. 2015;19(21):4195\u2013202.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"9","key":"1884_CR231","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1002\/ptr.5659","volume":"30","author":"S Rahmani","year":"2016","unstructured":"Rahmani S, Asgary S, Askari G, Keshvari M, Hatamipour M, Feizi A, et al. Treatment of non-alcoholic fatty liver disease with curcumin: A randomized placebo\u2010controlled trial. Phytother Res. 2016;30(9):1540\u20138.","journal-title":"Phytother Res"},{"issue":"1","key":"1884_CR232","first-page":"898361","volume":"2014","author":"S Ganjali","year":"2014","unstructured":"Ganjali S, Sahebkar A, Mahdipour E, Jamialahmadi K, Torabi S, Akhlaghi S, et al. Investigation of the effects of Curcumin on serum cytokines in obese individuals: a randomized controlled trial. Sci World J. 2014;2014(1):898361.","journal-title":"Sci World J"},{"issue":"13","key":"1884_CR233","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1080\/10408398.2015.1077195","volume":"57","author":"B Kocaadam","year":"2017","unstructured":"Kocaadam B, \u015eanlier N. Curcumin, an active component of turmeric (Curcuma longa), and its effects on health. Crit Rev Food Sci Nutr. 2017;57(13):2889\u201395.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"1884_CR234","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1472-6882-6-10","volume":"6","author":"CD Lao","year":"2006","unstructured":"Lao CD, Ruffin MTt, Normolle D, Heath DD, Murray SI, Bailey JM, et al. Dose escalation of a curcuminoid formulation. BMC Complement Altern Med. 2006;6:10.","journal-title":"BMC Complement Altern Med"},{"issue":"20","key":"1884_CR235","doi-asserted-by":"publisher","first-page":"6847","DOI":"10.1158\/1078-0432.CCR-04-0744","volume":"10","author":"RA Sharma","year":"2004","unstructured":"Sharma RA, Euden SA, Platton SL, Cooke DN, Shafayat A, Hewitt HR, et al. Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance. Clin Cancer Res. 2004;10(20):6847\u201354.","journal-title":"Clin Cancer Res"},{"issue":"2","key":"1884_CR236","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1111\/j.1600-0773.1978.tb02240.x","volume":"43","author":"B Wahlstr\u00f6m","year":"1978","unstructured":"Wahlstr\u00f6m B, Blennow G. A study on the fate of Curcumin in the rat. Acta Pharmacol Et Toxicologica. 1978;43(2):86\u201392.","journal-title":"Acta Pharmacol Et Toxicologica"},{"issue":"04","key":"1884_CR237","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1055\/s-2006-957450","volume":"64","author":"G Shoba","year":"1998","unstructured":"Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas P. Influence of Piperine on the pharmacokinetics of Curcumin in animals and human volunteers. Planta Med. 1998;64(04):353\u20136.","journal-title":"Planta Med"},{"issue":"4","key":"1884_CR238","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/0300-483X(81)90027-5","volume":"22","author":"V Ravindranath","year":"1981","unstructured":"Ravindranath V, Chandrasekhara N. Metabolism of curcumn-studies with [3H] Curcumin. Toxicology. 1981;22(4):337\u201344.","journal-title":"Toxicology"},{"issue":"1\u20132","key":"1884_CR239","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.jchromb.2007.03.010","volume":"853","author":"K-Y Yang","year":"2007","unstructured":"Yang K-Y, Lin L-C, Tseng T-Y, Wang S-C, Tsai T-H. Oral bioavailability of Curcumin in rat and the herbal analysis from curcuma longa by LC\u2013MS\/MS. J Chromatogr B. 2007;853(1\u20132):183\u20139.","journal-title":"J Chromatogr B"},{"issue":"3","key":"1884_CR240","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/0300-483X(80)90122-5","volume":"16","author":"V Ravindranath","year":"1980","unstructured":"Ravindranath V, Chandrasekhara N. Absorption and tissue distribution of Curcumin in rats. Toxicology. 1980;16(3):259\u201365.","journal-title":"Toxicology"},{"issue":"2\u20133","key":"1884_CR241","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/0300-483X(81)90056-1","volume":"20","author":"V Ravindranath","year":"1981","unstructured":"Ravindranath V, Chandrasekhara N. In vitro studies on the intestinal absorption of Curcumin in rats. Toxicology. 1981;20(2\u20133):251\u20137.","journal-title":"Toxicology"},{"issue":"5","key":"1884_CR242","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.3892\/ijmm.2016.2524","volume":"37","author":"J Jankun","year":"2016","unstructured":"Jankun J, Wyganowska-\u015awi\u0105tkowska M, Dettlaff K, Jeli\u0144ska A, Surdacka A, W\u0105tr\u00f3bska-\u015awietlikowska D, et al. Determining whether Curcumin degradation\/condensation is actually bioactivation (Review). Int J Mol Med. 2016;37(5):1151\u20138.","journal-title":"Int J Mol Med"},{"issue":"7636","key":"1884_CR243","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1038\/541144a","volume":"541","author":"M Baker","year":"2017","unstructured":"Baker M. Deceptive Curcumin offers cautionary Tale for chemists. Nature. 2017;541(7636):144\u20135.","journal-title":"Nature"},{"issue":"9","key":"1884_CR244","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1021\/acsmedchemlett.7b00284","volume":"8","author":"F Bahadori","year":"2017","unstructured":"Bahadori F, Demiray M. A realistic view on the essential medicinal chemistry of Curcumin. ACS Med Chem Lett. 2017;8(9):893\u20136.","journal-title":"ACS Med Chem Lett"},{"key":"1884_CR245","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.nut.2018.03.055","volume":"54","author":"MT Khayyal","year":"2018","unstructured":"Khayyal MT, El-Hazek RM, El-Sabbagh WA, Frank J, Behnam D, Abdel-Tawab M. Micellar solubilisation enhances the antiinflammatory activities of Curcumin and Boswellic acids in rats with adjuvant-induced arthritis. Nutrition. 2018;54:189\u201396.","journal-title":"Nutrition"},{"issue":"6","key":"1884_CR246","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1208\/s12249-018-1098-9","volume":"19","author":"MU Akbar","year":"2018","unstructured":"Akbar MU, Zia KM, Nazir A, Iqbal J, Ejaz SA, Akash MSH. Pluronic-Based mixed polymeric micelles enhance the therapeutic potential of Curcumin. AAPS PharmSciTech. 2018;19(6):2719\u201339.","journal-title":"AAPS PharmSciTech"},{"issue":"10","key":"1884_CR247","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.3390\/nu10101553","volume":"10","author":"X-Y Xu","year":"2018","unstructured":"Xu X-Y, Meng X, Li S, Gan R-Y, Li Y, Li H-B. Bioactivity, health benefits, and related molecular mechanisms of curcumin: current progress, challenges, and perspectives. Nutrients. 2018;10(10):1553.","journal-title":"Nutrients"},{"issue":"05","key":"1884_CR248","first-page":"420","volume":"83","author":"MC Falconieri","year":"2017","unstructured":"Falconieri MC, Adamo M, Monasterolo C, Bergonzi MC, Coronnello M, Bilia AR. New dendrimer-based nanoparticles enhance Curcumin solubility. Planta Med. 2017;83(05):420\u20135.","journal-title":"Planta Med"},{"issue":"1\u20132","key":"1884_CR249","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.ijpharm.2006.12.043","volume":"337","author":"W Tiyaboonchai","year":"2007","unstructured":"Tiyaboonchai W, Tungpradit W, Plianbangchang P. Formulation and characterization of curcuminoids loaded solid lipid nanoparticles. Int J Pharm. 2007;337(1\u20132):299\u2013306.","journal-title":"Int J Pharm"},{"key":"1884_CR250","doi-asserted-by":"crossref","unstructured":"Wang W, Zhu R, Xie Q, Li A, Xiao Y, Li K et al. Enhanced bioavailability and efficiency of Curcumin for the treatment of asthma by its formulation in solid lipid nanoparticles. Int J Nanomed. 2012:3667\u201377.","DOI":"10.2147\/IJN.S30428"},{"issue":"11","key":"1884_CR251","doi-asserted-by":"publisher","first-page":"2289","DOI":"10.3390\/ijms18112289","volume":"18","author":"N Skoupa","year":"2017","unstructured":"Skoupa N, Dolezel P, Ruzickova E, Mlejnek P. Apoptosis induced by the Curcumin analogue EF-24 is neither mediated by oxidative stress-related mechanisms nor affected by expression of main drug transporters ABCB1 and ABCG2 in human leukemia cells. Int J Mol Sci. 2017;18(11):2289.","journal-title":"Int J Mol Sci"},{"key":"1884_CR252","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.colsurfb.2017.07.027","volume":"158","author":"S Pieretti","year":"2017","unstructured":"Pieretti S, Ranjan AP, Di Giannuario A, Mukerjee A, Marzoli F, Di Giovannandrea R, et al. Curcumin-loaded Poly (d, l-lactide-co-glycolide) nanovesicles induce antinociceptive effects and reduce pronociceptive cytokine and BDNF release in spinal cord after acute administration in mice. Colloids Surf B Biointerfaces. 2017;158:379\u201386.","journal-title":"Colloids Surf B Biointerfaces"},{"issue":"6","key":"1884_CR253","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1080\/10408390902841529","volume":"49","author":"DJ McClements","year":"2009","unstructured":"McClements DJ, Decker EA, Park Y, Weiss J. Structural design principles for delivery of bioactive components in nutraceuticals and functional foods. Crit Rev Food Sci Nutr. 2009;49(6):577\u2013606.","journal-title":"Crit Rev Food Sci Nutr"},{"issue":"8","key":"1884_CR254","doi-asserted-by":"publisher","first-page":"R109","DOI":"10.1111\/j.1750-3841.2007.00507.x","volume":"72","author":"DJ McClements","year":"2007","unstructured":"McClements DJ, Decker EA, Weiss J. Emulsion-Based delivery systems for lipophilic bioactive components. J Food Sci. 2007;72(8):R109\u201324.","journal-title":"J Food Sci"},{"issue":"16","key":"1884_CR255","doi-asserted-by":"publisher","first-page":"6615","DOI":"10.1073\/pnas.1016217108","volume":"108","author":"A Hassaninasab","year":"2011","unstructured":"Hassaninasab A, Hashimoto Y, Tomita-Yokotani K, Kobayashi M. Discovery of the Curcumin metabolic pathway involving a unique enzyme in an intestinal microorganism. Proc Natl Acad Sci U S A. 2011;108(16):6615\u201320.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"1884_CR256","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.3390\/nu11092147","volume":"11","author":"M Dei Cas","year":"2019","unstructured":"Dei Cas M, Ghidoni R. Dietary curcumin: correlation between bioavailability and health potential. Nutrients. 2019;11(9):2147.","journal-title":"Nutrients"},{"issue":"4b","key":"1884_CR257","first-page":"2895","volume":"21","author":"AL Cheng","year":"2001","unstructured":"Cheng AL, Hsu CH, Lin JK, Hsu MM, Ho YF, Shen TS, et al. Phase I clinical trial of curcumin, a chemopreventive agent, in patients with high-risk or pre-malignant lesions. Anticancer Res. 2001;21(4b):2895\u2013900.","journal-title":"Anticancer Res"},{"issue":"4","key":"1884_CR258","doi-asserted-by":"publisher","first-page":"445","DOI":"10.4103\/0250-474X.44591","volume":"70","author":"B Antony","year":"2008","unstructured":"Antony B, Merina B, Iyer VS, Judy N, Lennertz K, Joyal S. A pilot Cross-Over study to evaluate human oral bioavailability of BCM-95CG (Biocurcumax), A novel bioenhanced Preparation of Curcumin. Indian J Pharm Sci. 2008;70(4):445\u20139.","journal-title":"Indian J Pharm Sci"},{"issue":"1","key":"1884_CR259","doi-asserted-by":"publisher","first-page":"37","DOI":"10.3177\/jnsv.61.37","volume":"61","author":"Y Sunagawa","year":"2015","unstructured":"Sunagawa Y, Hirano S, Katanasaka Y, Miyazaki Y, Funamoto M, Okamura N, et al. Colloidal submicron-particle Curcumin exhibits high absorption efficiency-a double-blind, 3-way crossover study. J Nutr Sci Vitaminol (Tokyo). 2015;61(1):37\u201344.","journal-title":"J Nutr Sci Vitaminol (Tokyo)"},{"issue":"1","key":"1884_CR260","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1475-2891-13-11","volume":"13","author":"R J\u00e4ger","year":"2014","unstructured":"J\u00e4ger R, Lowery RP, Calvanese AV, Joy JM, Purpura M, Wilson JM. Comparative absorption of Curcumin formulations. Nutr J. 2014;13(1):11.","journal-title":"Nutr J"},{"issue":"6","key":"1884_CR261","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1016\/j.jalz.2016.03.016","volume":"12","author":"M Prior","year":"2016","unstructured":"Prior M, Goldberg J, Chiruta C, Farrokhi C, Kopynets M, Roberts AJ, et al. Selecting for neurogenic potential as an alternative for alzheimer\u2019s disease drug discovery. Alzheimer\u2019s Dement. 2016;12(6):678\u201386.","journal-title":"Alzheimer\u2019s Dement"},{"issue":"6","key":"1884_CR262","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1590\/s0102-865020180060000008","volume":"33","author":"J Lv","year":"2018","unstructured":"Lv J, Cao L, Zhang R, Bai F, Wei P. A Curcumin derivative J147 ameliorates diabetic peripheral neuropathy in streptozotocin (STZ)-induced DPN rat models through negative regulation AMPK on TRPA1. Acta Cir Bras. 2018;33(6):533\u201341.","journal-title":"Acta Cir Bras"},{"issue":"6","key":"1884_CR263","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1093\/brain\/aws097","volume":"135","author":"SK Roy Chowdhury","year":"2012","unstructured":"Roy Chowdhury SK, Smith DR, Saleh A, Schapansky J, Marquez A, Gomes S, et al. Impaired adenosine monophosphate-activated protein kinase signalling in dorsal root ganglia neurons is linked to mitochondrial dysfunction and peripheral neuropathy in diabetes. Brain. 2012;135(6):1751\u201366.","journal-title":"Brain"},{"key":"1884_CR264","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.neuropharm.2017.11.007","volume":"129","author":"DJ Daugherty","year":"2018","unstructured":"Daugherty DJ, Marquez A, Calcutt NA, Schubert D. A novel Curcumin derivative for the treatment of diabetic neuropathy. Neuropharmacology. 2018;129:26\u201335.","journal-title":"Neuropharmacology"},{"issue":"5","key":"1884_CR265","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1021\/acs.jmedchem.6b00975","volume":"60","author":"KM Nelson","year":"2017","unstructured":"Nelson KM, Dahlin JL, Bisson J, Graham J, Pauli GF, Walters MA. The essential medicinal chemistry of curcumin: miniperspective. J Med Chem. 2017;60(5):1620\u201337.","journal-title":"J Med Chem"},{"issue":"6","key":"1884_CR266","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1021\/mp700113r","volume":"4","author":"P Anand","year":"2007","unstructured":"Anand P, Kunnumakkara AB, Newman RA, Aggarwal BB. Bioavailability of curcumin: problems and promises. Mol Pharm. 2007;4(6):807\u201318.","journal-title":"Mol Pharm"},{"issue":"12","key":"1884_CR267","doi-asserted-by":"publisher","first-page":"e27865","DOI":"10.1371\/journal.pone.0027865","volume":"6","author":"Q Chen","year":"2011","unstructured":"Chen Q, Prior M, Dargusch R, Roberts A, Riek R, Eichmann C, et al. A novel neurotrophic drug for cognitive enhancement and alzheimer\u2019s disease. PLoS ONE. 2011;6(12):e27865.","journal-title":"PLoS ONE"},{"issue":"2","key":"1884_CR268","doi-asserted-by":"publisher","first-page":"e12715","DOI":"10.1111\/acel.12715","volume":"17","author":"J Goldberg","year":"2018","unstructured":"Goldberg J, Currais A, Prior M, Fischer W, Chiruta C, Ratliff E, et al. The mitochondrial ATP synthase is a shared drug target for aging and dementia. Aging Cell. 2018;17(2):e12715.","journal-title":"Aging Cell"},{"issue":"4","key":"1884_CR269","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.3233\/JAD-170188","volume":"58","author":"M Tang","year":"2017","unstructured":"Tang M, Taghibiglou C. The mechanisms of action of Curcumin in alzheimer\u2019s disease. J Alzheimer\u2019s Disease. 2017;58(4):1003\u201316.","journal-title":"J Alzheimer\u2019s Disease"},{"issue":"1","key":"1884_CR270","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1186\/s12883-023-03358-5","volume":"23","author":"F Qiu","year":"2023","unstructured":"Qiu F, Wang Y, Du Y, Zeng C, Liu Y, Pan H, et al. Current evidence for J147 as a potential therapeutic agent in nervous system disease: a narrative review. BMC Neurol. 2023;23(1):317.","journal-title":"BMC Neurol"},{"key":"1884_CR271","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.nutres.2020.03.002","volume":"78","author":"MJ Banez","year":"2020","unstructured":"Banez MJ, Geluz MI, Chandra A, Hamdan T, Biswas OS, Bryan NS, et al. A systemic review on the antioxidant and anti-inflammatory effects of resveratrol, curcumin, and dietary nitric oxide supplementation on human cardiovascular health. Nutr Res. 2020;78:11\u201326.","journal-title":"Nutr Res"},{"key":"1884_CR272","doi-asserted-by":"publisher","first-page":"572533","DOI":"10.3389\/fpsyt.2020.572533","volume":"11","author":"T Ramaholimihaso","year":"2020","unstructured":"Ramaholimihaso T, Bouazzaoui F, Kaladjian A. Curcumin in depression: potential mechanisms of action and current Evidence-A narrative review. Front Psychiatry. 2020;11:572533.","journal-title":"Front Psychiatry"},{"issue":"1","key":"1884_CR273","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s13195-017-0277-3","volume":"9","author":"D Daugherty","year":"2017","unstructured":"Daugherty D, Goldberg J, Fischer W, Dargusch R, Maher P, Schubert D. A novel alzheimer\u2019s disease drug candidate targeting inflammation and fatty acid metabolism. Alzheimers Res Ther. 2017;9(1):50.","journal-title":"Alzheimers Res Ther"},{"issue":"3","key":"1884_CR274","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/alzrt179","volume":"5","author":"M Prior","year":"2013","unstructured":"Prior M, Dargusch R, Ehren JL, Chiruta C, Schubert D. The neurotrophic compound J147 reverses cognitive impairment in aged alzheimer\u2019s disease mice. Alzheimers Res Ther. 2013;5(3):25.","journal-title":"Alzheimers Res Ther"},{"key":"1884_CR275","doi-asserted-by":"publisher","first-page":"755","DOI":"10.3389\/fnins.2017.00755","volume":"11","author":"T Jia","year":"2018","unstructured":"Jia T, Rao J, Zou L, Zhao S, Yi Z, Wu B, et al. Nanoparticle-encapsulated Curcumin inhibits diabetic neuropathic pain involving the P2Y12 receptor in the dorsal root ganglia. Front NeuroSci. 2018;11:755.","journal-title":"Front NeuroSci"},{"key":"1884_CR276","doi-asserted-by":"crossref","unstructured":"Katagiri A, Shinoda M, Honda K, Toyofuku A, Sessle BJ, Iwata K. Satellite glial cell P2Y12 receptor in the trigeminal ganglion is involved in lingual neuropathic pain mechanisms in rats. Molecular pain. 2012;8:1744-8069-8-23.","DOI":"10.1186\/1744-8069-8-23"},{"key":"1884_CR277","doi-asserted-by":"publisher","first-page":"790747","DOI":"10.3389\/fendo.2021.790747","volume":"12","author":"R Bhandari","year":"2022","unstructured":"Bhandari R, Sharma A, Kuhad A. Novel Nanotechnological approaches for targeting dorsal root ganglion (DRG) in mitigating diabetic neuropathic pain (DNP). Front Endocrinol. 2022;12:790747.","journal-title":"Front Endocrinol"},{"key":"1884_CR278","doi-asserted-by":"publisher","first-page":"755","DOI":"10.3389\/fnins.2017.00755","volume":"11","author":"T Jia","year":"2017","unstructured":"Jia T, Rao J, Zou L, Zhao S, Yi Z, Wu B, et al. Nanoparticle-Encapsulated Curcumin inhibits diabetic neuropathic pain involving the P2Y12 receptor in the dorsal root ganglia. Front Neurosci. 2017;11:755.","journal-title":"Front Neurosci"},{"issue":"6","key":"1884_CR279","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.nano.2013.01.001","volume":"9","author":"RP Joshi","year":"2013","unstructured":"Joshi RP, Negi G, Kumar A, Pawar YB, Munjal B, Bansal AK, et al. SNEDDS Curcumin formulation leads to enhanced protection from pain and functional deficits associated with diabetic neuropathy: an insight into its mechanism for neuroprotection. Nanomedicine. 2013;9(6):776\u201385.","journal-title":"Nanomedicine"}],"container-title":["Diabetology &amp; Metabolic Syndrome"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-025-01884-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13098-025-01884-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13098-025-01884-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T14:59:20Z","timestamp":1757343560000},"score":1,"resource":{"primary":{"URL":"https:\/\/dmsjournal.biomedcentral.com\/articles\/10.1186\/s13098-025-01884-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,5]]},"references-count":279,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1884"],"URL":"https:\/\/doi.org\/10.1186\/s13098-025-01884-5","relation":{},"ISSN":["1758-5996"],"issn-type":[{"value":"1758-5996","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,5]]},"assertion":[{"value":"2 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the ethical committee of the saveh University of Medical Sciences, saveh, Iran.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"314"}}